Peptide Design for Mesenchymal Stem Cell Specific Attachment on Apatite Surfaces for Bone Tissue Regeneration. by Ramaraju, Sriharsha
 
 
 
 
 
 
 
Peptide Design for Mesenchymal Stem Cell Specific Attachment on Apatite Surfaces 
for Bone Tissue Regeneration 
 
by 
 
 
Sriharsha Ramaraju 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Biomedical Engineering) 
in The University of Michigan 
2015 
 
 
 
 
 
 
 
 
Doctoral Committee: 
 
 Professor David H. Kohn, Chair 
 Professor Renny T. Franceschi 
 Associate Professor Andrew J. Putnam  
 Professor Jan P. Stegemann 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Sriharsha Ramaraju 
All Rights Reserved 
2015 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
To my family 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
ACKNOWLEDGMENTS 
This work would not have been possible without the mentorship and support provided by 
my graduate advisor David Kohn. Thanks for providing me the freedom to develop my 
own scientific curiosity while facilitating access to necessary resources. Thank you as 
well for allowing me to seek out and pursue my professional interests. I would like to 
thank my dissertation committee, Dr. Franceschi, Dr. Stegemann, and Dr. Putnam, for 
their insightful feedback that improved the focus of my research questions.  
I would like to thank my labmates whom I’ve had the pleasure of working with over the 
years. Thank you Janani Ramaswamy, Erin McNerny, and Joseph Gardinier for the long 
chats that helped me shape my scientific questions and the many ice-cream and coffee 
breaks.  Thank you Genny Romanowicz for your various academic and confectionary 
contributions. I would like to thank Nianli Zhang, Nicholas Landgraf and Michelle Lynch 
for their assistance with various experimental procedures. Thank you Nadder Sahar, Linh 
Luong, and Michael Friedman for your constructive feedback during presentations.  A 
special thanks to Sharon Miller for applying phage-display technology to bone tissue 
engineering, identifying the peptides that are the focus of this work, and for being a co-
author on my publications.  
I would like to thank Dr. Paul Krebsbach’s lab. Specifically, I would like to thank Dr. 
Hongli Sun for assistance with animal surgeries, and Dr. Luis Villa-Diaz for generating 
iPS-MSCs and assistance with iPS-MSC characterization which allowed me to complete 
iv 
 
my subsequent aims. I would also like to thank Dr. Sergei Kuznetsov for the generous 
contribution of primary MSCs derived from human bone marrow stroma. I would also 
like to thank Chris Strayhorn from the Dental Histology Core, Taocong Jin from the 
Dental Molecular biology core, Dr. Henriette Remmer at the Proteomics Core, and the 
staff at the microscopy and image analysis core for speeding up materials and data 
acquisition. I would also like to thank our past and present administrative staff Liz 
Rodriguiz, Kumud Danak, Deb Keedy, Joel Clandenin, and Maria Steele for making 
things run smoothly.  
I would like to thank and acknowledge my undergraduate research advisor Dr. Alfred H. 
Merrill, Jr for introducing me to academic research and providing me the opportunity to 
continue my undergraduate research beyond graduation. I would like to thank Dr. Dennis 
Liotta, Dr. John Petros, Dr. Carrie Sun and Dr. Rebecca Arnold for providing me the 
guidance, environment, and confidence to broaden my research skills and experiences.  
I would like to thank all of my friends and my sister for their various visits to Ann Arbor 
when I was unable to travel and for enduring Michigan winters. I would like to thank my 
wife Neelima for being a constant source of strength throughout my graduate school. 
Your patience, positivity, and support were integral to the completion of this work.  
Lastly, I would like to thank my parents for the struggles they’ve endured and the 
sacrifices they have made in order to provide me the opportunities to pursue my academic 
interests.  
 v 
TABLE OF CONTENTS 
DEDICATION ii 
ACKNOWLEDGMENTS iii 
LIST OF FIGURES viii 
LIST OF TABLES x 
LIST OF APPENDICIES xi 
ABSTRACT xii 
CHAPTER ONE: INTRODUCTION 1 
Clinical Significance 1 
Biomaterial Design 2 
Recapitulating Cellular Microenvironments 3 
Peptide Therapies for Tissue Regeneration 5 
Peptide Specificity 5 
Peptide Presentation 6 
Display Technologies for Peptide-based Tissue Regeneration Therapies 7 
Phage Display Peptides that Form the Basis for this Dissertation 8 
Summary of Significance 9 
Aims and Hypothesis 10 
References 15 
CHAPTER TWO: DUAL-FUNCTIONING PEPTIDES DISCOVERED BY PHAGE DISPLAY IMPROVE 
BMSC SPECIFIC ATTACHMENT TO MINERALIZED BIOMATERIALS 21 
Introduction 21 
Materials and Methods 23 
Biomaterial preparation 23 
Cell sources and culture 24 
Peptide synthesis 24 
Langmuir isotherms 25
 vi 
 
Cell attachment assays 26 
Cell morphology and immunohistochemistry 27 
Statistical methods 27 
Results 28 
Peptide binding isotherms on HA 28 
Cell adhesion strength on dual-peptide coated mineral 28 
HBMSC specificity to dual-peptide coated mineral 29 
MSC adhesion dependence on cell seeding density 29 
Discussion 30 
Acknowledgements 34 
References 45 
CHAPTER THREE: PHAGE DISPLAY DERIVED BI-FUNCTIONAL PEPTIDE IMPROVES MSC 
ADHESION, PROLIFERATION AND DIFFERENTIATION ON APATITE 49 
Introduction 49 
Materials and Methods 51 
Mineralized film fabrication 51 
Peptide synthesis and adsorption to bone-like mineral 52 
Cell Culture 52 
Competitive adhesion of MSC 53 
Cell spreading and histomorphometry 53 
Msc Differentiation On Peptide Coated Apatite 54 
Peptide Cell Internalization 55 
MSC Recruitment on Peptide Coated Apatite 55 
Statistical Methods 56 
Results 56 
MSC Spreading And Contact Distribution On Peptide Coated Apatite 56 
Competitive MSC Binding Assays 57 
MSC Proliferation On Peptide Coated Apatite 57 
MSC Differentiation On Peptide Coated Apatite 58 
Peptide Internalization 59 
Multipotent-MSC Recruitment From Murine Bone Marrow 59 
Discussion 59 
Acknowledgements 63 
References 76 
CHAPTER FOUR: IMPROVING MSC BASED BONE TISSUE REGENERATION IN VIVO USING CELL-
SPECIFIC PEPTIDE COATED MINERALIZED BIOMATERIALS 80 
Introduction 80 
Materials and Methods 84 
Scaffold Fabrication 84 
Scaffold Mineralization 84 
 vii 
Scaffold Characterization 85 
Peptide Synthesis and Characterization 86 
Peptide loading and Characterization 86 
Cell Culture 87 
Subcutaneous Transplantation of Cell-Seeded Constructs 88 
Ossicle Microcomputed Tomography 89 
Ossicle Histology and Histomorphometry 89 
Statistical Methods 90 
Results 90 
Characterization of Mineralized Scaffolds 90 
Peptide Loading on Mineralized Scaffolds 91 
Cell Attachment and Distribution on Peptide-Laden Scaffolds 91 
Ossicle Bone Volume Fraction and Distribution 92 
Histology of Reconstructed Ossicles 93 
Regression Analysis 93 
Discussion 94 
Acknowledgements 99 
References 117 
CHAPTER FIVE: SUMMARY AND FUTURE WORK 122 
Phage display derived peptide design 124 
Dual-peptide tissue engineering applications 125 
Future directions 126 
Advancements in display technology 129 
References 130 
 
APPENDICIES  135 
 
 
 
 
 
 viii 
LIST OF FIGURES 
 
CHAPTER ONE FIGURES  
Figure 1.1 Overview of Aims 14 
CHAPTER TWO FIGURES  
Figure 2.1 (A,B). Langmuir isotherms 37 
Figure 2.2(A-E). HBMSC attachment, adhesion strength and spreading on single and dual-
functioning peptide coated apatite films 38 
Figure 2.3(A-D). MSC specific adhesion strength and spreading on DPI-VTK and RGD-VTK 
coated apatite films. 41 
Figure 2.4(A-C). Cell seeding density effects on cell spreading on VTK and DPI-VTK coated 
apatite films. 43 
CHAPTER THREE FIGURES  
Figure 3.1(A-E) Cell spreading and contact distribution on peptide coated apatite surfaces 65 
Figure 3.2(A-C). iPS-MSC competition with soluble integrin binding competitors. 68 
Figure 3.3. MSC proliferation on peptide coated apatite substrates. 70 
Figure 3.4(A-G). IPS-MSC differentiation on TCPS in osteogenic media. 71 
Figure 5(A-F). Differentiation of iPS-MSCs on biomimetic apatite and peptide coated apatite 73
 ix 
Figure 3.6. Cell association of fluorescently tagged VTK peptide after 1 hr of incubation. 74 
Figure 3.7. Multipotent murine-MSC recruitment onto peptide coated apatite  75 
 
CHAPTER FOUR FIGURES  
Figure 4.1(A-J) Morphology and distribution of bone-like mineral precipitated on PLGA 
scaffolds 101 
Figure 4.2(A-H). Peptide adsorption and distribution on mineralized PLGA Scaffolds. 103 
Figure 4.3(A-G) - Cell Seeding efficiency and cell distribution on peptide coated scaffolds. 105 
Figure 4.4(A-H). Bone volume fractions of ectopically regenerated ossicles 8 weeks post 
transplantation. 108 
Figure 4.5(A-H). Bone distribution in ectopically regenerated ossicles 8 weeks post 
transplantation. 111 
Figure 4.6(A-K). Histological staining and bone quality scoring of ectopically regenerated 
ossicles 8 weeks post transplantation. 114 
 
 x 
LIST OF TABLES 
 
CHAPTER TWO TABLES  
Table 2.1 Aim 1 Peptide Properties 35 
Table 2.2: Binding isotherm results 36 
CHAPTER THREE TABLES  
Table 3.1 Peptide Properties 64 
CHAPTER FOUR TABLES  
Table 4.1 Peptide Properties 99 
Table 4.2 Histology scoring parameters 100 
 xi 
LIST OF APPENDICIES 
Appendix A Adsorption Isotherm             135 
Appendix B Cell Centrifugation Assay            138 
 xii 
ABSTRACT 
 
Over 2 million bone grafting procedures are performed annually worldwide for the 
treatment of bone defects. Cell transplantation therapies are promising alternatives to 
conventional auto-, allo-, and xenograft therapies. Successfully delivering stem and 
progenitor cells to the defect site requires biomaterials that support and guide 
reconstruction. Biomaterial functionalization with extracellular matrix derivatives to 
improve adhesion and guide tissue regeneration lacks specificity towards particular 
regenerative cell populations. In order to direct cell specific adhesion to specific 
biomaterial surface chemistries, we used a combinatorial phage display strategy to 
identify 2 sequences, 1 with high affinity towards apatite (VTK) and a second with high 
affinity to clonally derived mesenchymal stem cells (MSC) from human bone marrow 
stroma (DPI) and combined the two sequences into a dual-functioning peptide (DPI-
VTK).   
Dual-functioning peptide DPI-VTK exhibited greater apatite binding compared to single 
peptide controls (p < 0.01). Mesenchymal stem cells on DPI-VTK coated apatite 
substrates exhibited greater adhesion strength compared to pre-osteoblasts and fibroblasts 
(p <0.01). DPI-VTK also increased MSC spreading (p < 0.001) and proliferation (p < 
0.001) compared to apatite controls while supporting differentiation on apatite substrates. 
Competitive inhibition revealed RGD-binding integrin involvement in MSC attachment 
 xiii 
to DPI-VTK. MSC driven bone formation, cellularity and vascularization in a 
subcutaneous mouse model were greater on DPI-VTK coated PLGA-mineral composite 
scaffolds compared to VTK (p < 0.017) and uncoated controls (p <0.001) and acellular 
peptide-coated controls (p <0.002).  Taken together, DPI-VTK improves MSC specific 
attachment and subsequent adhesion on mineralized substrates driving greater 
proliferation and bone formation compared to acellular and non-peptide coated controls.  
A vast array of biomaterials and multitude of regenerative cell sources are available for 
tissue regeneration applications. As tissue engineering shifts from developing 
technologies to meet general clinical challenges to addressing more focused clinical 
applications, there will be an increased need for delivering cell specific cues to material 
surfaces with defined surface chemistries. Combinatorial phage display is a powerful 
platform to enable focused cell based tissue regeneration through the discovery of cell 
specific and material specific peptide sequences.
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CHAPTER ONE 
 INTRODUCTION 
 
CLINICAL SIGNIFICANCE  
 
Current clinical solutions for tissue replacement and regeneration utilize auto-, allo- or 
xenografts which require multiple interventional procedures and could result in donor site 
morbidity and immunogenicity[1], [2]. De novo tissue regeneration utilizing cells 
extracted from the host offers a promising alternative to the current clinical standards. 
Most organ systems in the body contain a repository of stem and progenitor cells that 
replace dying and injured cells to preserve the integrity of tissues. For instance, cells of 
the bone marrow stroma contain a mesenchymal population that can give rise to 
osteogenic, chondrogenic, myogenic, and adipogenic lineages[1], [3], [4]. These cells 
secrete tropic factors to improve tissue repair, suppress immune responses and are a 
readily available and relatively non-invasive cell source to extract from the host. 
Moreover, stem and progenitors can be expanded in monolayer culture or 3D culture 
under perfusion to be delivered to a defect site on an appropriate transplant material[3], 
[5]–[8]. Stem and progenitor cell mediated bone regeneration in vivo is dependent on 
biomaterial properties that control cell seeding efficiency, and cell distribution, and can 
provide instructive cues to guide cell proliferation and differentiation[9]–[12].
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BIOMATERIAL DESIGN 
The ideal 3D biomaterial provides an environment that allows cell adhesion and 
encourages cell growth and differentiation while allowing transport of nutrients and 
waste to facilitate new tissue formation[8], [13].   A conductive biomaterial supports cell 
adhesion, which is an important starting point for functional tissue regeneration.  In 
addition to the number of cells seeded on a 3D biomaterial construct, the distribution of 
cells plays a critical role in bone formation as well. Constructs that improve cell seeding 
density and promote uniform distribution of cells in a 3D biomaterial while directing cell-
cell communication and cell-matrix interactions are hypothesized to improve bone 
formation in vivo[9], [14], [15].  
Both bulk and surface properties of a material contribute to cell adhesion. Metals, 
ceramics, polymers, and composites are used in conjunction with an array of surface and 
bulk modification techniques to yield material properties conducive to supporting cell 
based tissue regeneration [2], [8], [16]–[18]. In the context of bone, properties such as 
compliance, surface free energy, wettability, surface topography, and crystallinity 
influence cell mediated bone formation in vivo[19]–[21]. Many of these properties exhibit 
collinear relationships due to the underlying biological processes driving cell adhesion, 
proliferation, and differentiation.  
Osteoinductive biomaterials stimulate and drive differentiation of primitive 
undifferentiated pluripotent or multipotent cells towards a terminal bone forming cell 
lineage[22]. Inductive biomaterials utilize growth factors, recombinant DNA, and 
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peptides to regulate cell growth and differentiation[22]–[24]. These biomolecules can be 
adsorbed, encapsulated within or immobilized to biomaterials in order to temporally and 
spatially control transplanted cell behavior. The conductive and inductive properties of a 
material that impact cell adhesion, proliferation, and differentiation result in an expansive 
number of design considerations for developing the ideal carrier for functional tissue 
regeneration. Biomimetic biomaterial design strategies specifically addresses 
osetoconduction and osteoinduction by recapitulating physical and chemical attributes of 
the native ECM to drive functional tissue regeneration[25]–[28].   
RECAPITULATING CELLULAR MICROENVIRONMENTS  
Biomimetic design of biomaterials involves studying the physical and chemical 
properties of functional tissues and incorporating these properties into biomaterial design. 
The extracellular matrix (ECM) of bone is comprised of 50-70% inorganic mineral 
matrix, 20-40% organic matrix, 5-10% water and less than 3% lipids. The inorganic 
matrix is comprised of a non-stoichiometric, semi-crystalline, calcium and hydroxide 
deficient carbonate substituted hydroxyapatite mineral [Ca10(PO4)6(OH)2]. The organic 
matrix is predominantly comprised of Type I collagen. Non-collagenous proteins 
comprise the remaining 10-15% of the organic component and include proteoglycans, 
glycosylated proteins, and γ-carboxylated proteins. These non-collagenous proteins are 
involved in directing organic matrix assembly, maintaining structural integrity of the 
tissue, sequestering and interacting with growth factors, and regulating bone metabolism 
and mineralization.  Both the organic and inorganic components of bone contribute to 
conductive and inductive properties. Therefore reproducing aspects of both organic and 
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inorganic components of bone tissue in biomaterial design is hypothesized to improve 
regeneration. 
Surface coating via a biomimetic procedure can be used to form a biomimetic apatite 
coating on biocompatible and biodegradable polymer substrates.  For instance, 3D porous 
poly-Lactide-co-Glycolide (PLGA) scaffold surfaces can be coated with a continuous 
bone like mineral (BLM) layer through immersion in a supersaturated simulated body 
fluid (SBF). This SBF contains similar ionic concentrations to that of blood plasma and 
results in the precipitation of a bone-like-mineral that is semicrystalline, nano-structured, 
and is carbonate substituted [29]–[31].  Biomimetically mineralized polymers exhibit a 5-
fold increase in compressive modulus, support higher bone marrow stromal cell adhesion 
through well distributed fibrillar contacts, and higher bone volume fractions when used to 
transplant BMSCs in vivo compared to non-mineralized polymer scaffolds[18], [29], 
[32], [33].  
The organic components of extracellular matrices are comprised of collagenous and non-
collagenous proteins that provide mechanical support and cell instructive cues that 
facilitate tissue growth and preserve tissue integrity. These components impart cues that 
regulate an elegant sequence of spatially and temporally controlled events resulting in 
tissue repair and regeneration. Collagen, fibronectin, vitronectin, osteocalcin, 
osteopontin, bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 
(FGF-2) have all been used to drive osteoblastic differentiation of and improve quantity 
of regenerated bone [34]–[36]. However, full length recombinant ECM proteins are 
challenged by degradation rate, conformational control, and high processing costs.  
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PEPTIDE THERAPIES FOR TISSUE REGENERATION 
 
Peptide epitopes offer a promising alternative to protein based therapies by allowing 
control of conformation, cell and material specificity, degradation rate, and reduced 
processing costs.  Peptides derived from the active sites of ECM proteins have been used 
to impart instructive cues to stem and progenitor cell lines that form bone [34], [36]–[38]. 
The method of delivering these signals onto a biomaterial and the modification of these 
peptides play an important role in mediating cell responses. Peptide delivery methods 
involve adsorption, covalent immobilization or encapsulation into a biomaterial. 
Adsorption of peptides on a biomaterial surface involves weak molecular and 
electrostatic forces at the substrate-peptide interface. While adsorption allows 
conformational freedom of peptides, it is challenged by control of release rates and short 
half-lives of some unbound peptide. Peptide mediated control of cell viability, 
differentiation, and tissue formation, are variable across cell sources, materials, and mode 
of delivery. This variability can be linked to both the specificity of the peptide sequences 
to cell lineages and the proper presentation of these sequences suggesting the important 
interplay of these factors.  
PEPTIDE SPECIFICITY  
The cell binding sites of ECM protein domains exhibit different binding affinities to 
different integrin receptors. For instance, DGEA and GFOGER peptides from collagen 
predominantly bind to α2β1 integrin receptors, whereas fibronectin and vitronectin 
fragments bind α5β1 receptors. Most ECM proteins also have multiple binding domains 
that interact and contribute to this specificity. As an example,  the RGD sequence 
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prevalent in many proteins binds αVβ3 integrins whereas co-delivery with the fibronectin 
sequence PHSRN synergistically improves binding affinity to α5β1[34], [38]–[40]. 
Targeting different integrins results in variable cell responses across cell lineages. For 
instance, the DGEA collagen fragment and RGD preferentially bind different integrin 
subunits and increase FAK signaling pathways, but only the DGEA peptide improves 
MAPK mediated signal transduction [41]. Differences in specificity for these integrin 
receptors could also be responsible for variability of tissue regeneration in vivo.   For 
example, collagen derived peptides improve MSC cell differentiation in vitro and bone 
formation in vivo, whereas RGD exhibits inverse effects [41], [42].    
In addition to using components of known ECM peptides, novel cryptic peptides from 
collagen have also been derived to improve conductive properties [43], [44]. Strategies 
using components of known ECM proteins targeting specific integrins lack specificity to 
a particular cell type. The ability to adhere and recruit specific stem or progenitor cell 
populations to a biomaterial surface and impart instructive cues can improve tissue repair 
and regeneration[38]. In addition to delivering cell specific sequences, proper 
presentation of these signals can also improve specificity, cell adhesion, proliferation and 
differentiation.  
PEPTIDE PRESENTATION 
In addition to different delivery methods, peptide structure and conformation can be 
altered to improve loading efficiency on biomaterials and binding affinity to cell surface 
receptors. For example, recapitulating the circular conformation of RGD that is 
commonly found in ECM proteins by altering the structure of RGD not only improves 
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solution stability and adsorption to biominerals, but also increases bone formation when 
immobilized on alginate hydrogels[45], [46].   
Many ECM proteins have multifunctional domains that work in conjunction with one 
another to present the cell instructive domains to the cell surface receptors. Combining 
the cell adhesive sequence with a material binding sequence can improve presentation of 
the cell instructive peptide to the cell and enhance cellular response[47], [48].  For 
example, peptide fragment 17-25 of the bone ECM protein osteocalcin contains 3 
glutamic acid residues at positions 17, 21, and 24. These residues strongly bind 
hydroxyapatite and have been used to improve RGD, BMP, and VEGF derived peptide 
adsorption to biomineral surfaces[37], [47]–[49]. Improving the binding affinity of the 
cell adhesive peptides by attaching them to material binding sequences improves cell 
proliferation, differentiation and mineralization in vitro.   
The combination of sequence specificity, peptide modification methods, and peptide 
loading methods with respect to the carrier material contribute to the presentation of the 
cell instructive cues to the cell surface.  Therefore, the ability to systematically design 
specific peptides and appropriately present them to the cell surface receptor can improve 
tissue regeneration.  
DISPLAY TECHNOLOGIES FOR PEPTIDE-BASED TISSUE REGENERATION 
THERAPIES 
Bacteriophage display, bacterial display and cell surface display technologies are 
commonly used in oncology and immunology to humanize targeted monoclonal 
antibody(MAb) based therapies[50], [51].  The application of phage display for tissue 
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regeneration is gaining traction through the development of biomaterial specific or cell 
specific peptides. Material specific peptides are used to increase physiochemical 
deposition of biomineral on biomaterials or deliver growth factors to the surface of 
mineralized biomaterials[52]–[55]. Cell binding phage-derived peptides have been 
tethered to polymer biomaterials or self-assembled into 3D structures to improve 
conductivity and inductivity [56]–[58] . Phage-derived mimetic peptides of the enamel 
protein amelogenin improve cell conductivity and tissue formation in vivo[59].  
PHAGE DISPLAY PEPTIDES THAT FORM THE BASIS FOR THIS 
DISSERTATION 
The primary aim of this dissertation is to evaluate the bone forming potential of MSCs 
specifically tethered to an apatite surface using a phage display derived apatite specific 
peptide combined with a cell specific peptide.  A commercially available M13 
bacteriophage display kit containing 10
9
 sequences of 12-mers was used to identify 
biomineral and cell specific sequences to improve the specificity of  human bone marrow 
stromal cell binding to apatite surfaces[60], [61].  
After 3 rounds of phage panning on HA disks and BLM coated PLGA films, 243 
sequences were identified. Amongst these 243 sequences, 68 sequences were identified 
as high information clones through RELIC analysis. From the 68 sequences, 19 were 
ordered in terms of their binding affinity to different crystal faces of HA [001, 200], and 
10 sequences were selected for ELISA on PLGA, BLM-PLGA films, HA disks, and 
tissue cultured polystyrene(TCPS). The top 5 sequences exhibiting positive ELISA 
signals, compared to high information clones from RELIC, and high binding affinity 
sequences form computational modeling resulted in 3 consensus sequences. Adsorption 
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assays measuring efficiency of peptide binding to apatite, resulted in the identification of 
1 peptide sequence, VTKHLNQISQSY (VTK), with superior binding affinity to 
BLM[50], [60], [61].  
After 3 rounds of phage panning on BMSCs, 50 recurring sequences were identified, 
amongst which 27 were high information clones and 10 high information and 10 low 
information peptides were tested using immunohistochemistry (IHC). From the 50 
sequences identified, the MOTIF1 program identified continuous motif sequences 3 and 4 
amino acids long as NHT, and (S/T)(I/V)LS. Although no consensus sequences were 
found from MOTIF1 and RELIC analysis, two sequences were identified as having high 
scores from both RELIC and IHC. A cell adhesion assay with BMSCs attached to peptide 
laden BLM coated PLGA films and peptide coated TCPS resulted in the identification of 
1 sequence, DPIYALSWSGMA (DPI), that improves cell seeding efficiency on BLM in 
vitro[60]. The cell specific and mineral specific peptides were combined using glycine 
residues to yield GGDPIYALSWSGMAGGGSVTKHLNQISQSY (DPI-VTK).  
In addition to combining these peptides, post-translational modification of the mineral 
binding sequence improves apatite binding affinity in vitro. Many naturally occurring 
ECM proteins contain phosphorylated serine residues which improve apatite binding 
affinity. Phosphorylation of the C-terminal serine residues of VTK improves binding 
affinity to apatite but reduces cell adhesion to apatite surfaces [60].  
SUMMARY OF SIGNIFICANCE 
The ability to provide specific cues to stem and progenitor cells is an increasing area of 
focus for biomaterial design.  Combining these cues with material specific cues can have 
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broad implications for tissue regeneration. Dual functioning peptides could impart spatial 
control over cell adhesion and differentiation, which can translate to increased quantity 
and quality of tissue regenerated in vivo. Moreover, dual functioning peptides containing 
material and cell specific domains could also be translated to enhance mineralized 
implant integration in vivo.  
AIMS AND HYPOTHESIS 
The primary aims of this dissertation were to: 1) design and verify peptide functionality towards 
specifically recruiting MSCs to mineral substrates. 2) assess osteoconduction and osteoinduction 
of MSCs on dual peptide coated biomimetic apatite surfaces in vitro, and 3) examine the 
relationship between initial cell attachment and peptide distribution on dual peptide coated 3D 
mineralized PLGA scaffolds in-vitro and the quantity, quality and distribution of regenerated 
bone in vivo. 
Global hypothesis: Combining material and cell specific peptides into a dual-functioning 
peptide can improve initial cell attachment, cell-specific adhesion, proliferation and 
differentiation in vitro and improve quality, quantity and distribution of bone formation 
in vivo compared to non-specific peptides or specific peptides with only a single 
functionality.   
The overall aim of this thesis is to demonstrate the utility of phage display 
technologies towards improving cell-specific attachment to biomaterials contributing to 
increased proliferation, differentiation and tissue regeneration. With the growing 
abundance of regenerative cell sources, it will become increasingly important to control 
cell specific delivery and recruitment to biomaterial surfaces (Figure 1.1).  
 11 
Aim 1: Quantify material binding affinity and MSC binding affinity of dual functioning 
peptide  
Hypothesis: Combining a mineral specific peptide sequence with a clonally-derived 
HBMSC specific peptide sequence will improve the binding affinity of cell specific 
peptides to mineralized substrates and subsequently improve cell specific adhesion to 
mineralized substrates   
Aim 1.1: Quantify the influence of mineral binding sequence on dual functioning 
peptide binding affinity to mineralized biomaterials with Langmuir isotherms  
Hypothesis: Attaching phage display derived mineral specific sequences 
to human bone marrow stromal cell specific sequences will improve the 
binding affinity of the dual sequence to mineral surfaces in vitro 
Aim 1.2: Quantify dual functioning peptide specificity to human bone marrow 
stromal cells with a cell detachment assay  
Hypothesis: Addition of a mineral binding sequence to a cell specific 
sequence to yield a dual functioning peptide can improve initial HBMSC 
attachment to 2D mineralized surfaces in vitro 
Chapter 2, which relates to Aim 1, demonstrates the ability of our combinatorial phage 
display process to select material-specific and cell-specific sequences with dual 
functionality. The dual peptide DPI-VTK exhibits strong affinity towards hydroxyapatite 
and biomimetic apatite while concomitantly promoting MSC specific adhesion on apatite 
surfaces.  
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Aim 2: Determine effects of dual functioning peptides on HBMSC specific adhesion, 
proliferation, and differentiation on 2D mineral films in vitro  
Hypothesis: Dual functioning peptides improve cell spreading and influence 
proliferation and differentiation on 2D mineral films in vitro   
Chapter 3, which relates to Aim 2, demonstrates the ability of the dual peptide DPI-VTK 
to improve cell adhesion and promotes cell proliferation by binding an RGD-integrin 
specific receptor. There was only a marginal improvement of MSC differentiation on 
DPI-VTK compared to uncoated apatite films; however, MSC specificity towards DPI-
VTK, improved adhesion compared to untreated mineral and cooperative interactions 
with serum proteins translate to improved cell delivery for tissue regeneration in vivo. 
Aim 3: Demonstrate that dual functioning peptides improve HBMSC seeding efficiency 
and distribution on biomimetically mineralized PLGA scaffolds and consequently 
improve quantity, distribution and quality of bone formation in vivo 
Hypothesis: Dual functioning peptides improve cell seeding efficiency and distribution 
of HBMSCs on biomimetically mineralized PLGA scaffolds, which correlates with 
improved quantity, distribution, and quality of bone formation in vivo. 
Chapter 4, which relates to Aim 3, demonstrates the ability of dual peptide DPI-VTK to 
improve the quantity, cellularity and vascularization of bone formation in vivo compared 
to uncoated controls. Although bone quantity, cellularity and vascularization of 
reconstructed ossicles were greater on DPI-VTK coated constructs, ossicles still exhibited 
a shell of bone formation with less bone volume in the interior. Regardless, the quantity 
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of regenerated bone was significantly improved by coating DPI-VTK on mineralized 
scaffolds for cell-based tissue regeneration.  
Overall, this work demonstrates the specificity and bioactivity of DPI-VTK in vitro and 
its osteogenic potential in vivo while demonstrating the significance of display 
technology towards tissue regeneration applications. 
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CHAPTER ONE FIGURES 
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CHAPTER TWO 
DUAL-FUNCTIONING PEPTIDES DISCOVERED BY PHAGE 
DISPLAY IMPROVE BMSC SPECIFIC ATTACHMENT TO 
MINERALIZED BIOMATERIALS 
 
INTRODUCTION 
Cell based tissue regeneration is a promising alternative to auto-, allo- or xenografts [1], [2].  
Regeneration of large defects in vivo using transplanted stem and progenitor cells is dependent on 
having a biomaterial carrier with surface properties that maximize cell attachment and promote 
cell growth, differentiation and formation of functional extracellular matrix (ECM) [3]–[6]. 
Additionally, designing a biomaterial that can promote adhesion of specific cell populations can 
improve the efficiency of cell based therapies [7].  
In the context of bone tissue engineering, inorganic biomaterials and mineralized synthetic or 
natural polymers, as well as polymer-mineral composites are often used to deliver physical and 
chemical cues to drive osteogenesis [8]–[10].  Biomaterials with a mineral component provide a 
favorable environment for osteogenic differentiation of stem and osteogenic progenitor cells. 
Providing cell-specific and cell-instructive cues on the mineral component can further improve 
osteogenic differentiation and bone formation. For example, functionalizing mineralized 
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biomaterials  with ECM proteins increases cell attachment, proliferation and differentiation, 
leading to increased bone healing [11]–[13].  
Peptides derived from the functional domains of ECM proteins have been used to direct stem and 
progenitor cells toward a bone lineage [7], [11], [14], [15]. Peptide delivery methods involve 
adsorption, covalent immobilization or encapsulation into a biomaterial. The method of delivery 
along with post-synthesis modification involving cyclization, post-translational modification, and 
combining with other peptides  play an important role in mediating cell responses (17). 
Adsorption is the primary mode of peptide delivery to mineral surfaces since covalent 
immobilization is not possible. Therefore the accessibility of cell binding domains once the 
peptide is delivered to a mineral substrate is an important design consideration.  
Variability of peptide mediated cell attachment, proliferation, differentiation and tissue 
regeneration can be linked to both the lack of proper presentation of these sequences to cells and 
a lack of peptide specificity to certain sequences [16], [17]. For example, recapitulating the 
cyclized conformation of the RGD motif prevalent in native ECM proteins increases adsorption 
to biominerals, and also increases cell adhesion and subsequent bone formation when 
immobilized on alginate hydrogels [12], [18].  Furthermore, a competitive interaction between 
peptide coatings and serum proteins can have an inhibitory effect on tissue regeneration. For 
instance,  RGD peptide coatings on HA reduce serum protein adsorption through charge-charge 
repulsions[19]. In addition to changing the structure of a peptide, a dual functioning peptide 
having a material adsorption component can independently control the presentation of the cell 
binding sequence to cell surface receptors [13], [20].  
Many ECM proteins have multifunctional domains that work in conjunction with one another to 
present cell instructive domains to cell surface receptors. In addition to a cell binding sequence, 
incorporating a second sequence that tethers the peptide to a biomaterial can recapitulate these 
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ECM multifunctional domains.  For example, peptide fragment 17-25 of the bone ECM protein 
osteocalcin contains 3 glutamic acid residues at positions 17, 21, and 24. These residues strongly 
bind hydroxyapatite and improve RGD, BMP, and VEGF derived peptide adsorption to 
biomineral surfaces [13], [15], [20], [21]. Increased control of cell binding peptide presentation to 
cell surface by combining them to appropriate material binding peptides can  improve cell 
proliferation, differentiation and mineralization in vitro [21], [22].   
Peptide sequence, post-translational modification, peptide conformation, and peptide loading 
method influence presentation of the cell instructive cues to the cell surface. By combining cell 
adhesive peptides with specific material binding domains, we can systematically control factors 
that influence cell recognition. This ability to systematically design specific peptides and 
appropriately present them to the cell surface can improve cell-material interactions, leading to 
greater quantity and quality of regenerated tissue in vivo.  
We have identified peptides specific for human bone marrow stromal cells (hBMSC) 
(DPIYALSWSGMA, DPI) and apatite surfaces (VTKHLNQISQSY,VTK) using phage display. 
The primary aims of this study were to combine cell specific DPI sequence with VTK and 
measure apatite binding affinity, hBMSC adhesion strength, and specificity to hBMSCs when the 
apatite and cell-specific peptides are combined into a dual functioning peptide.  
MATERIALS AND METHODS 
BIOMATERIAL PREPARATION 
Hydroxyapatite disks (HA) for the phage display experiments (10 mm diameter x 4 mm thick) 
were pressed from powder (Plasma Biotal Ltd. P220) at 1 metric ton for 1 minute and sintered at 
1350°C for 5 hours (heating rate of 10°C/minute). Biomimetic apatite films were used to model a 
heterogeneous apatite surface similar to the inorganic bone microenvironment to characterize cell 
attachment. Apatite films were prepared by immersing PLGA thin films in simulated body fluid 
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to precipitate carbonate substitute apatite with plate like nanofeatures. A 5 w/v% 85:15 
polylactic-co-glycolic acid (PLGA, Alkermes)-chloroform solution was cast on 15mm diameter 
glass slides. The PLGA films were etched in 0.5M NaOH and immersed in modified simulated 
body fluid (mSBF) for 5 days at 37°C with fluid changes every 24 hrs. The mSBF was made by 
dissolving the following reagents in Millipore water at 25°C and titrating to pH 6.8 using NaOH: 
141 mM NaCl, 4.0 mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM 
CaCl2•2H2O, and 2.0 mM KH2PO4.  
CELL SOURCES AND CULTURE 
Clonally derived human bone marrow stromal cells (hBMSC), were a generous gift from the 
NIH[23], [24].  Murine bone marrow stromal cells(mBMSCs) were harvested from femora and 
tibiae of 5-6 week old C57/BL 6 mice (Jackson Laboratories). All BMSCs  were maintained in 
alpha minimum essential media (α-MEM) (Gibco, #12561) with glutamine containing 20% fetal 
bovine serum (FBS) and antibiotics (100 U/mL penicillin, 0.1 mg/mL streptomycin (P/S)) 
(Gibco, #15140) at 37°C in a 5% CO2 incubator. Induced Pluripotent Stem Cell derived MSCs 
(IPS-MSC) were a generous gift from Dr. Paul Krebsbach. IPS-MSCs were maintained in (α-
MEM), 20% FBS, antibiotics, 200mM L-glutamine, and 10mM non-essential amino acids. 
MC3T3-E1 and mouse dermal fibroblasts (MDFs) were a gift from Dr. Renny Franceschi. 
MC3T3-E1 cells and mouse dermal fibroblasts were cultured in alpha minimum essential media 
(α-MEM), 10% FBS, and antibiotics. All cells were passaged when they reached 80-90% 
confluence. Media was replaced every 2-3 days. 
PEPTIDE SYNTHESIS 
Single and dual function experimental and control peptides were synthesized using solid phase 
synthesis and protective chemistry (Table 2.1). High performance liquid chromatography was 
used to verify > 95% purity. Peptides were stored at -20
o
C until use in each experiment.  
 25 
LANGMUIR ISOTHERMS 
Peptides were solubilized in water and diluted in Trizma buffer (pH 7.5). Photometric readings 
for peptide standard curves and samples were taken at 25
o
C using a multi-well plate reader 
measuring UV absorbance from 205-240nm at 5nm increments. The absorbance wavelength that 
produced the best linear curve fit for standards was used to calculate sample concentrations 
before and after the adsorption assay. This wavelength varied between 205-215nm for single 
peptides and 230-235nm for dual peptides.  Isotherm studies were conducted using HA powder 
with an average particle size of 18-30 μm and a surface area of 50m2/g suspended in Trizma 
buffer pH 7.5 for 2-3 hrs at 37
o
C prior to experiments. A powder presents a relatively high 
surface to volume ratio allowing less peptide usage in a smaller volume. Adsorption assays were 
conducted by incubating an HA suspension and peptide solution in a 96-well Millipore filter plate 
for 3hr at 37
o
C under agitation. Solution was filtered into a fresh 96-well plate and the amount of 
unbound peptide was determined using UV absorbance and standards. Bulk peptide 
concentrations tested ranged from 0-2000µg/mL. Material specific peptides demonstrated no 
affinity towards tissue culture polystyrene surfaces, negating the possibility of non-specific 
binding. To assess peptide affinity to apatite, Langmuir isotherms of bulk versus bound peptide 
were constructed to determine binding affinity (1/KD) and maximal adsorption concentration  
(Vmax) using the following equation: [25], [26]  
  
  
 
     
    
 
Where Cb is the bulk concentration of peptide and Cs is the concentration of peptide bound to 
substrate, and KD is the dissociation constant. Two experiments were done, each with 3 
replicates(n=6). The Gibbs free energy of adsorption      
  was calculated as previously 
described[27] using the following equation:  
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Where the gas constant (R) = 8.314 J mol
-1
 K
-1
, ambient temperature (T) = 310 K, and the molar 
concentration of solvent water is Csolv = 55.5 mol L
-1
. 
CELL ATTACHMENT ASSAYS 
Biomimetic apatite films were incubated in ddH2O overnight to remove excess salts, and then 
incubated in Trizma buffer prior to use. Mineralized films were attached to the bottom of 24 well 
plates with sticky tabs. Films were subsequently incubated in 100 μg/mL of peptide solution for 3 
hrs, washed and blocked with 1% denatured BSA to reduce non-specific cell attachment. The 
amount of peptide on apatite coated films was quantified using UV absorbance and a BCA assay. 
Loading efficiency on biomimetic apatite was not significantly different across peptide groups. 
Cell centrifugation assays using hBMSCs, IPS-MSCs, mBMSCs, MC3T3s and MDFs were 
conducted using a seeding density of 35,000 cells/cm
2
.  Peptide coated films, no peptide controls, 
and films used for standard curves were incubated with cells for 3hrs at 37
o
C and 5% CO2 in 
serum-free media. Peptide coated films and no-peptide controls were subsequently washed, wells 
were filled with PBS, inverted, sealed and centrifuged with forces of 10
-8
 10
-7
 dynes using an 
Eppendorf 5810r centrifuge[28], [29]. At forces above 10
-6
 dynes, mineral and FITC-BSA were 
washed away. Detached cells were removed, and cell numbers on peptide coated films, no 
peptide controls and standard curves were determined using the WST-1 assay (Clontech 
Laboratories, Inc.). Adherent cell fractions on peptide coated apatite groups were normalized to 
no-peptide biomimetic apatite film controls at each centrifugation speed. Half-cell detachment 
forces (τ50) were calculated by fitting the remaining adherent cell fraction(%)  to sigmoidal curves 
using the Boltzmann equation.  
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Where L1 = lower asymptote, L2 = upper asymptote,    is the inflection point, and     is the 
slope at the inflection point. A least squares regression with the current data allows for 
determination of these parameters. The τ50 values, detachment force where 50% cells are 
detached, are determined using these parameters.  Using excel solver, a least squares regression 
was done with bounded constraints on x0. 
CELL MORPHOLOGY AND IMMUNOHISTOCHEMISTRY 
A range of hBMSC seeding densities spanning 1,000-50,000 cells/cm
2 
was used to demonstrate 
the interplay between initial cell seeding density and seeding efficiency on dual-peptide coated 
apatite surfaces. Mineralized peptide coated and uncoated controls containing adherent cells from 
detachment forces assays and seeding density experiments were washed twice in PBS, fixed in 
10% formalin buffer, permeabilized in Triton X, and stained with Rhodhamine-
Pholloidin(ThermoFisher Scientific) for F-Actin and mounted in Vectashield containing DAPI 
(Vectorlabs) on glass coverslips.  Images were acquired with a NIKON Ti-Eclipse Confocal 
Microscope using a 20x objective. Images from 4 samples per group and 10 fields per 
sample(n=40) were analyzed using Image J software (NIH). Each field was analyzed for cell 
number using the dapi stain, total cell spread area marked by F-actin stain, and total cell spread 
area per cell was calculated from the initial two measurements.    
STATISTICAL METHODS 
Single factor ANOVA was used to determine differences in binding affinity, half-cell detachment 
forces and quantitative histomorphometry amongst the different peptides using Sigmastat. Two-
way ANOVA on ranks with Tukey test pairwise comparisons and interactions was used to 
determine differences and interaction between peptide groups across seeding densities.  
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RESULTS 
PEPTIDE BINDING ISOTHERMS ON HA 
Mineral binding and dual peptides reached an adsorption equilibrium between 0-1000µg/mL 
indicating apatite saturation (Fig 2.1a,b). The phosphorylated mineral specific sequence VTKphos 
demonstrated a greater binding affinity to apatite than VTK (Table 2.2). The concentration 
required to reach the equilibrium condition is lower for VTKphos than for VTK. The dual-
functioning phage derived peptides DPI-VTK (p<0.001), DPI-VTKphos, (p <0.01) and dual 
functioning peptide with cell binding control RGD-VTK (p < 0.01) demonstrated higher binding 
affinities than the single peptides. DPI-VTK had a lower KD than DPI-VTKphos (p < 0.01). 
Although the acidic residues in E7 bind strongly with the cationic components of HA, the binding 
affinity of RGD-E7 was lower than predominantly charge neutral RGD-VTK and DPI-VTK 
(p<0.01).  
Values for Vmax were within the range of reported monolayer adsorption concentrations 
for proteins and peptides [25], [26]. Moreover, calculated Vmax values based on cross-sectional 
area of each peptide in a linear and cyclic conformation fall within the range of experimentally 
observed values(Table 2.2). Vmax for single peptides was higher than dual peptides (p < 0.01) with 
the exception of RGD-E7.   
CELL ADHESION STRENGTH ON DUAL-PEPTIDE COATED MINERAL 
Dual peptides RGD-VTK and RGD-E7 yielded the highest cell attachment when no force 
was applied compared to remaining peptide coated and control groups (Fig. 2.2a,  p < 0.01). 
However, as forces were applied, larger cell fractions were adherent to DPI-VTK compared to 
other peptide coated and control groups. Consequently, τ50 for the DPI-VTK sequence was 
higher than for the rest of the peptides (Fig. 2.2b, p<0.01).  
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HBMSCs exhibited a more spread morphology on RGD-VTK, DPI-VTK and RGD-E7 
compared to other peptides (Fig. 2.2c). The total surface area covered by cells was greater on 
RGD-VTK and RGD-E7 coated surfaces, however, spread area/cell was greater on DPI-VTK 
compared to RGD-VTK and RGD-E7 (Fig. 2.2d,e  p<0.01).  
HBMSC SPECIFICITY TO DUAL-PEPTIDE COATED MINERAL 
HBMSCs, mBMSCs and IPS-MSCs bound more strongly to DPI-VTK than murine pre-
osteoblasts and fibroblasts (Fig. 2.3a, p<0.01). RGD-VTK bound weakly to hBMSCs, however it 
promoted stronger adhesion to MC3T3s and MDFs than DPI-VTK (p < 0.01). Although IPS-
MSC adhesion to DPI-VTK was greater than to RGD-VTK (p < 0.01), IPS-MSCs demonstrated 
similar adhesion strength on RGD-VTK compared to pre-osteoblasts and fibroblasts.  
HBMSC morphology on DPI-VTK and RGD-VTK (Fig. 2.2c) was rounder and less 
spread compared to mBMSC and IPS-MSC morphology on these peptides (Fig. 2.3b). MC3T3s 
and MDFs  spread more on RGD-VTK compared to DPI-VTK. Conversely, MSCs spread more 
on DPI-VTK compared to RGD-VTK.  Total cell spread area was greater on RGD-VTK 
compared to DPI-VTK across all cell types (p < 0.01), with the exception of mBMSCs. However, 
spread area normalized to number of MSCs was greater on DPI-VTK compared to RGD-VTK 
and the converse relationship was observed with MC3T3 and MDFs (Fig. 2.3c).  
HBMSCs on RGD-VTK had higher total cell spread area than MC3T3 and MDF. This 
indicates that more hBMSCs bound RGD-VTK, but MC3T3s and MDFs bound and spread more 
favorably on these surfaces. This could arise from interplay between cell spreading and cell 
density after initial cell attachment.  
MSC ADHESION DEPENDENCE ON CELL SEEDING DENSITY 
 Adherent cell numbers are dependent on peptide groups and initial cell seeding density 
(p<0.001). The total cell coverage area is correlated with initial cell seeding density (p < 0.05) 
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which is stronger than the correlation between spread area per cell and initial seeding density. The 
interaction between initial seeding density, initial cell attachment and spread area per cell can be 
observed at the higher seeding densities 50, 40, and 30 k cells/cm
2
(Fig. 2.4a). DPI-VTK improves 
initial cell attachment on apatite compared to VTK. However at 50k cells/cm
2
, although the total 
spread area is higher on DPI-VTK, there is equivalent spread area/cell to that of VTK (Fig. 2.4 
b,c). This indicates a surface saturation of hBMSCs on VTK. HBMSCs exhibit more spreading 
on DPI-VTK at 40k cells/cm
2
 compared to 50k cells/cm
2
 but spread area/cell on DPI-VTK and 
VTK at 50k cells/cm
2
 is not significantly different. Moreover, there is no significant difference 
between spread area/cell between HBMSCs on DPI-VTK at 30k cells/cm
2
 and HBMSCs on VTK 
at 50k cells/cm
2
.  Trends in spread area per cell between both peptides across various densities 
are aligned with data attained at a seeding density of 37.5 k cells/cm
2
 for cell centrifugation 
assays.  
DISCUSSION 
 HBMSC specific peptide sequences were identified using a combinatorial phage display. 
Apatite-specific peptide sequences were similarly identified using a combinatorial phage display 
[30] and in this study were combined with cell-specific sequences to create dual functioning 
peptides with one domain having preferential affinity for a specific material chemistry and a 
second domain having preferential affinity for a specific cell population.  
Both cell and mineral binding domains contributed to the binding of dual functioning 
peptides to apatite (Table 2.2). Phosphorylation is a common post translational modification in 
natural ECM peptides and proteins that interact with mineral [16], [31]. Molecular dynamics 
simulations of dentin phosphoproteins(DPP) reveal un-phosphorylated DPP peptide derivatives 
are more mobile, flexible, and can fold over HA surfaces however phosphorylated peptides drive 
mineral association [32]. Although phosphorylation drives apatite binding affinity of DPP and 
osteopontin derived ASARM peptides,  it is the glutamic and aspartic acid residues that are 
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involved in binding the apatite surface [32], [33]. These data indicate the interplay between 
sequence, conformation, charge distribution and apatite affinity of phosphorylation which could 
all be contributing to the differences between DPI-VTK and DPI-VTKphos compared to VTKphos 
and VTK. Moreover, RGD-E7, which has an acidic mineral binding motif, had the lowest binding 
affinity amongst the dual functioning peptides. The KD values for RGD-E7 (Table 2.2) are 
consistent with studies using similar materials and assay conditions [21]. Conformational and 
charge distributions of bound peptide could also be contributing to the differences in Vmax. Single 
peptides can pack more efficiently because of smaller size, however the increased saturation 
concentration of RGD-E7 could be a result of non-Langmuir kinetics and potential aggregation in 
the solution state. Taken together, peptide sequence and conformation also contribute to packing 
efficiency.  
The half-cell detachment force is the force at which 50% of the initially bound cell 
population becomes detached. Detachment forces are a surrogate for how strongly cells attach to 
the substrate. The strength of attachment is related to the formation of specific peptide and cell 
surface receptor interactions. Since the adhesion timeframe in serum-free media allows for initial 
attachment only, the detachment force correlates with the average number of peptide-cell ligand 
interactions over a population of cells [29]. The dual-functioning phage derived peptide DPI-
VTK had the highest hBMSC adhesion strength (Fig. 2.3b). Although VTK and VTKphos 
exhibited similar initial attachment to DPI-VTK, they did not exhibit the same level of adhesion 
strength as DPI-VTK.  This indicates that adhesion strength of cells to DPI-VTK is largely driven 
by the interaction with the DPI domain of the peptide.  
Moreover, the weaker attachment of hBMSCs to DPI-VTKphos  compared to DPI-VTK 
(Fig. 2.3b) indicates that phosphorylating the mineral sequence compromises the presentation of 
the DPI sequence to the cell. Favorable binding to apatite and improved adhesion strength to 
hBMSCs of DPI-VTK, compared to DPI-VTKphos, indicates an involvement indirect effect of the 
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cell specific sequence on mineral association and an indirect effect of mineral sequence in 
directing cell association. For instance, adding DPI to the VTK sequence could lead to 
conformational changes to either the mineral or cell binding sequences that enhance mineral 
binding affinity. Once bound, association with the biomimetic apatite could cause another 
structural change in either DPI or VTK, resulting in a change in affinity to cell binding targets.  
Structural changes occur in both solution and apatite-bound states and can drive adsorption of 
peptides [34]–[36].  
More hBMSCs were initially bound to RGD-VTK, RGD-E7, DPI-VTK, and DPI-
VTKphos compared to VTK and VTKphos (Fig. 2.3a). The increase in cell attachment to these 
peptides also indicates that hBMSC cell surface receptors bind to both DPI and RGD peptides, as 
expected. Although there was less initial cell attachment on DPI-VTK compared to RGD-VTK, 
DPI-VTK was more favorable for cell spreading (Fig. 2.3d), a finding that also supports the 
adhesion data as force is applied (Fig. 2.3a). The prevalence of more spread cells indicates more 
cell-matrix interactions that result in stronger attachment forces.  
The adhesion strength of MSCs to DPI-VTK was greater than to MC3T3-E1 cells and 
MDFs (Fig. 2.4a).  This data indicates that the phage derived peptide has interactions that are 
specific to cell-surface receptors on MSCs, and verifies that phage display is capable of yielding 
cell-specific peptide sequences. Although hBMSCs demonstrated higher initial attachment to 
RGD-VTK and RGD-E7 (Fig. 2.3a), the weaker adhesion strength is indicative of weak 
association between hBMSC binding targets and RGD when presented with either E7 or VTK 
material binding sequences. Another driver of DPI-VTK specificity to MSCs could arise from 
differential integrin expression profiles of MC3T3c and MDFs compared to MSCs.  
Initial cell seeding density plays a critical role in the degree of cell spreading. This 
supports the contributions of both cell-cell and cell-substrate interactions to cell adhesion. The 
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differences in hBMSC spreading on DPI-VTK and VTK at 50k, 40k, and 30k cells/cm
2
 (Fig. 2.4) 
indicate an interaction between cell density and peptide function. HBMSCs are able to attach 
specifically to DPI-VTK and have sufficient room to spread below the seeding density of 30k - 
40k cells/cm
2
. However, as seeding density increased to 50k cells/cm
2
, initial cell attachment was 
so prevalent that the cells were unable to spread past a critical threshold. Initial cell attachment, 
subsequent adhesion and spreading, and density of seeded cells all contribute to tissue 
regeneration.   
Phage display identifies sequences that bind strongly to markers expressed on the cell 
surface. The absence of highly acidic residues in either set of sequences is an interesting outcome 
of the phage selection process. Phage display has been used to identify peptides that target 
biomaterials [37], [38], as well as stem, progenitor, carcinogenic and bacterial cells (22,23,34), 
and there is a bias for hydrophobic peptide selection [39]. The prevalence of hydrophobic 
sequences could be an artifact of the selection process and needs to be further explored. Although 
this hydrophobic bias seems counterintuitive for apatite binding, it could be a promising tool for 
biomolecule delivery. Peptides with acidic residues that react with the defined periodicity of Ca
2+
 
ions in the HA crystal lattice also interfere with the adsorption of serum proteins [19], [40]. For 
instance, RGD improves cell attachment, proliferation and differentiation in vitro, but has varied 
results in vivo. This could be both a function of how cells attach and spread on RGD covered 
surfaces and how the presence of RGD interferes with adsorption of serum proteins. Moreover, 
RGD is not specific to any particular cell type and can react with various integrin subunits. 
Therefore, using a hydrophobic mineral binding sequence like VTK to deliver a human bone 
marrow stromal cell specific sequence like DPI will not only anchor cell-specific sequences to 
HA surfaces, but could also allow adsorption of serum proteins and facilitate specific cell 
mediated tissue regeneration. The results collectively indicate that phage display can be used to 
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identify cell specific hBMSCs and material specific peptides that improve cell attachment and 
spreading on biomaterial surfaces, potentially leading to improved regeneration.  
DPIYALSWSGMA was identified as a high MSC binding sequence. This peptide was 
combined with previously identified mineral binding sequence VTKHLNQISQSY to specifically 
recruit MSCs to biomimetic apatite substrates. The dual peptide DPI-VTK increased binding 
affinity to apatite compared to cell, mineral, and dual peptide controls. Moreover, DPI-VTK 
improved MSC attachment and specificity, and promoted cell promote spreading on apatite. 
These data demonstrate the utility of phage display to recruit specific cell populations to specific 
biomaterial substrates.  
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CHAPTER TWO TABLES 
TABLE 2.1 AIM 1 PEPTIDE PROPERTIES  
Peptide Sequence Description 
MW 
(g/mol) 
Net 
Charge 
Acidic 
residues 
VTK VTKHLNQISQSY 
Phage derived mineral 
binding sequence 
 
1417.59 
 
1 2 
VTKphos VTKHLNQISpQSpY 
Phosphorylated phage 
derived mineral 
binding sequence 
(control) 
1577.55 
 
-3 2 
RGD GRGDS Cell binding control 
346.34 
 
0 1 
DPI DPIYALSWSGMA 
Phage derived cell 
binding sequence 
1310.49 
 
-1 3 
DPI-VTK 
GGDPIYALSWSGMAGG
GSVTKHLNQISQSY 
Dual functioning 
phage derived 
peptide 
3025.35 
 
0 5 
DPI-
VTKphos 
GGDPIYALSWSGMAGG
GSVTKHLNQISpQSpY 
Dual functioning 
mineral binding 
control sequence 
3185.31 
 
-5 5 
RGD-
VTK 
GGRGDGGGSVTKHLNQ
ISQSY 
Dual functioning cell 
binding control 
2061.20 
 
1 3 
RGD-E7 EEEEEEEPRGDT 
Dual functioning 
peptide control 
1448.00 
 
-7 8 
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TABLE 2.2: BINDING ISOTHERM RESULTS 
 Kd. 
(µM) 
Vmax 
(μmol/cm2) 
ΔGads 
(kJ)/mol 
r
2
 
 
VTK 
 
74.57±3.59 
 
30.67±5.44 
 
-34.8 
 
0.94 
 
VTKphos * 
 
32.67±1.69 
 
21.49±4.35 
 
-37.0 
 
0.93 
 
RGD-E7  
 
74.13±3.47 
 
328.86±54.39 
 
-34.9 
 
0.95 
 
RGD-VTK** 
 
7.36±0.35 
 
4.92±2.56 
 
-40.8 
 
0.90 
 
DPI-VTKphos** 
 
5.04±0.55 
 
30.05±6.41 
 
-41.8 
 
0.97 
 
DPI-VTK*** 
 
2.68±0.57 
 
17.94±3.22 
 
-43.4 
 
0.93 
 
* significantly different from RGD-E7 and VTK(p <0.01) 
**significantly different from dual peptides * and ***(p<0.01) 
ΔG= -RT Ln(Csolv/Kd)    R = 8.314 J mol
-1
 K
-1
 T = 310 K Csolv = 55.5 mol/L 
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CHAPTER TWO FIGURES 
FIGURE 2.1 (A,B). LANGMUIR ISOTHERMS 
 
 
Figure 2.1. Langmuir isotherms of A)mineral binding and B)dual functioning peptides on HA 
powder. Cb is the bulk concentration of peptide in solution and Cs is the bound concentration of 
peptide on hydroxyapatite particles. Data points represent triplicates from 2 separate adsorption 
studies (n=6).  
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FIGURE 2.2(A-E). HBMSC ATTACHMENT, ADHESION STRENGTH AND 
SPREADING ON SINGLE AND DUAL-FUNCTIONING PEPTIDE COATED 
APATITE FILMS 
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Figure 2.2. HBMSC attachment, adhesion strength and spreading on single and dual-functioning 
peptide coated apatite films. A) Cell attachment across different peptide groups exposed to a 
range of detachment forces(n=6).  *denotes significance from unmarked peptide groups within 
detachment forces (p <0.01). B) Half-cell detachment forces calculated from sigmoidal curve-
fitting of cell attachment data indicating force at which 50% of the initially adherent cell 
populations become detached (n=6). * denotes difference form remaining peptide groups 
(p<0.01). C) Representative confocal microscopy images at 40x depicting cell spreading on 
peptide coated apatite films. F-actin labeled with Rhodhamine-Pholloidin and nuclei labeled 
with DAPI. Scale bars 10µm. D) Total cell spread area calculated from Image J analysis of 
Pholloidin-stained area (n=4 per group x 10 FOV per sample). * denotes different from 
unmarked groups(p<0.01) E) Area /cell calculated from Image J(NIH) analysis of Pholloidin-
stained area (n=4 per group x 10 FOV per sample). * denotes different from unmarked 
groups(p<0.01) 
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FIGURE 2.3(A-D). MSC SPECIFIC ADHESION STRENGTH AND SPREADING 
ON DPI-VTK AND RGD-VTK COATED APATITE FILMS. 
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Figure 2.3. MSC specific adhesion strength and spreading on DPI-VTK and RGD-VTK coated 
apatite films. A) Half-cell detachment forces calculated from sigmoidal curve-fitting of cell 
attachment data indicating force at which 50% of the initially adherent cell populations become 
detached (n=6). Bars denote differences between peptide groups (p <0.01). * denotes difference 
form MC3T3 and MDFs in peptide coated groups. B) Representative confocal microscopy images 
at 40x depicting spreading on peptide coated apatite films. F-actin labeled with Rho-Pholloidin 
and nuclei labeled with DAPI. Scale bars 10µm. C) Total cell spread area calculated from Image J 
analysis of Pholloidin-stained area (n=4 per group x 10 FOV per sample Bars denote difference 
within cell type (p<0.01). D) Area /cell calculated from Image J(NIH) analysis of Pholloidin-
stained area (n=4 per group x 10 FOV per sample). * denotes greater than RGD-VTK(p<0.01). # 
denotes greater than DPI-VTK (p<0.01). 
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FIGURE 2.4(A-C). CELL SEEDING DENSITY EFFECTS ON CELL 
SPREADING ON VTK AND DPI-VTK COATED APATITE FILMS. 
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Figure 2.4. Cell seeding density effects on cell spreading on VTK and DPI-VTK coated apatite 
films. A) Representative confocal microscopy images at 20x depicting cell spreading on peptide 
coated apatite films. F-actin labeled with Rho-Pholloidin and nuclei labeled with DAPI. Scale bars 
20µm. B) Total cell spread area calculated from Image J analysis of Pholloidin-stained area (n=4 
per group x 10 FOV per sample Bars denote difference within cell type (p<0.01).* denotes 
difference from VTK (p < 0.01)  C) Area/cell calculated from Image J(NIH) analysis of Pholloidin-
stained area (n=4 per group x 10 FOV per sample). * denotes difference from VTK (p < 0.01) 
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CHAPTER THREE 
PHAGE DISPLAY DERIVED BI-FUNCTIONAL PEPTIDE 
IMPROVES MSC ADHESION, PROLIFERATION AND 
DIFFERENTIATION ON APATITE  
INTRODUCTION 
Cell based tissue regeneration strategies often require a biomaterial carrier with defined 
surface chemistries. With the proliferation of biomaterials and regenerative cell sources, 
it is important to recruit specific regenerative cell populations to specific biomaterial 
chemistries to meet clinical challenges[1]. In addition to attachment of specific cell 
populations, filling critical sized defects with adequate transplanted cell numbers 
becomes non-trivial. Improving the seeding efficiency of transplanted cell populations on 
biomaterial carriers can have a significant impact on reducing material requirements, 
healing time and  healthcare costs[2].  
Mesenchymal stem cells (MSCs) are a promising source for cell-based tissue 
regeneration [3], [4]. MSCs can form various tissues, including bone, cartilage, 
hematopoiesis-supporting stroma, and fat. In addition to multi-potent tissue formation, 
MSCs are immunomodulatory and can induce angiogenesis .  Since their initial discovery 
in the bone marrow stromal niche, MSCs have been identified in various adult and 
neonatal tissues including but not limited to adipose tissue, peripheral blood, amniotic 
fluid, and umbilical cord[5]. MSCs can also be derived from embryonic and induced 
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pluripotent stem cell (iPS) lineages[6]–[8]. Furthermore, induced pluripotent stem cell 
derived MSCs (iPS-MSCs) provide a more continuous supply compared to other sources 
of MSCs since they can be programmed from more readily available somatic sources. 
MSCs are characterized by their ability to adhere to plastic, proliferate readily in vitro 
and form multi-lineage tissue in vivo. A profile of cell surface markers, STRO-1, CD146, 
CD105, CD49a, positive for human bone marrow stroma and, CD34−, CD45−, CD14−, 
negative for hematopoietic and endothelial lineages are also used to verify MSC sub-
populations[9]. However, there are no markers or set of markers that can separate 
multipotent MSCs from non-multipotent MSCs[10], [11].  
Improving specific attachment of multipotent MSCs to biomaterials towards cell-based 
therapies can improve in vivo tissue regeneration outcomes. In the context of bone tissue 
regeneration, materials containing a mineral component are used to mechanically and 
chemically support transplanted cell populations. Precipitation of a heterogeneous layer 
of biomimetic apatite on biomaterial surfaces by immersion in simulated body fluid 
(SBF) under physiological conditions improves osteoconductivity and mechanical 
properties of the underlying substrate[12], [13]. Adsorption of extracellular matrix cell 
binding proteins,  functional peptide domains, and peptide motifs onto biomaterial 
surfaces can further enhance cell attachment[14], [15]. Mineral binding peptide domains 
and peptide motifs are also adsorbed to mineral surfaces to improve delivery of cell 
signals[16], [17]. Furthermore, peptide-based strategies to target α2β1 integrin domains 
that are highly expressed in MSCs have been used to improve cell-specific attachment to 
mineral[18], [19]. In addition to being osteoconductive,  these peptides exhibit 
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osteoinductivity by mechanotransductively regulating osteogenic signal transduction 
cascades within adherent MSCs[19]–[21].  
However ECM peptide domains targeting integrins do not exhibit cell specificity; rather, 
they target cell surface receptors prevalent across many cell types. Using a combinatorial 
phage display we have identified peptides specific towards multipotent-MSCs clonally 
derived  from human bone marrow stromal cells (hBMSC) (DPIYALSWSGMA, DPI) 
and apatite surfaces (VTKHLNQISQSY,VTK) and demonstrated conserved  mineral and 
cell specificity when the peptides are combined into a single dual-functioning peptide 
(DPI-VTK)[22], [23] .  In addition to mediating cell-specific attachment to apatite 
surfaces, in vitro spreading, proliferation, and differentiation are important indicators of 
biological performance. This study characterizes multi-potent MSC spreading and 
cytoskeletal contact distribution in the presence and absence of serum proteins, identifies 
biological targets for DPI mediated MSC attachment, assesses MSC proliferation and 
differentiation on DPI-VTK coated biomimetic apatite surfaces, and examines selectivity 
towards multi-potent MSC subpopulations.   
MATERIALS AND METHODS 
MINERALIZED FILM FABRICATION  
Biomimetic apatite films were used to characterize cell adhesion, proliferation and 
differentiation in vitro. Apatite films were prepared by immersing PLGA thin films in 
simulated body fluid to precipitate carbonated apatite with plate like nanofeatures. A 5 
w/v% 85:15 polylactic-co-glycolic acid (PLGA, Lakeshore Biomaterials)-chloroform 
solution was cast on 15mm diameter glass slides. The PLGA films were etched in 0.5M 
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NaOH and immersed in modified simulated body fluid (mSBF) for 5 days at 37°C with 
fluid changes every 24 hrs. The mSBF was made by dissolving the following reagents in 
Millipore water at 25°C and titrating to pH 6.8 using NaOH: 141 mM NaCl, 4.0 mM 
KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2•2H2O, and 2.0 
mM KH2PO4.  
PEPTIDE SYNTHESIS AND ADSORPTION TO BONE-LIKE MINERAL 
Single, dual-function, and fluorescently labeled peptides were synthesized using solid 
phase synthesis and protective chemistry (Table 3.1). HPLC was used to verify > 95% 
purity. Peptides were stored at -20
o
C until use. HBMSC specific peptide sequences were 
combined with previously identified mineral binding sequences VTK and 
VTKphos(Chapter 2). Films were subsequently incubated in 100 μg/mL of peptide 
solution for 3 hrs, washed and blocked with 1% denatured BSA to reduce non-specific 
cell attachment. The amount of peptide on apatite coated films was quantified using UV 
absorbance and a Pierce™ BCA assays (ThermoFisher Scientific ). Loading efficiency on 
biomimetic apatite was not significantly different across peptide groups 12.35±3nmol. 
CELL CULTURE 
Clonally derived human bone marrow stromal cells (hBMSC), were a generous gift from 
the NIH[24], [25].  Cells were maintained in alpha minimum essential media (α-MEM) 
(Gibco, #12561) with glutamine containing 20% fetal bovine serum (FBS) and antibiotics 
(100 U/mL penicillin, 0.1 mg/mL streptomycin (P/S)) (Gibco, #15140) at 37°C in a 5% 
CO2 incubator. Induced Pluripotent Stem Cell derived MSCs (iPS-MSC) verified for 
multi-potency were a generous gift from Dr. Paul Krebsbach[7]. iPS-MSCs were 
maintained in (α-MEM), 20% FBS, antibiotics, 200mM L-glutamine, and 10mM NEAA. 
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Cells were cultured in alpha minimum essential media (α-MEM), 10% FBS, and 
antibiotics. Cells were passaged when they reached 80-90% confluence was replaced 
every 2-3 days. Human bone marrow stromal cells were plated at 3000 cells/cm
2
 for 
spreading (n=6/group) and proliferation assays (n=6/group). Mineralized films were held 
in place with Teflon O-rings for proliferation assays to prevent films from floating.  
COMPETITIVE ADHESION OF MSC  
iPS-MSCs were incubated in the presence of competing antibodies (Cell Signaling 
Technology, 10ug/mL) or soluble RGD (1, 0.1, 0.01mM) for 10 min at 37
o
C under slight 
agitation (n=6/group) [26]–[28]. Mineralized films were attached to the bottom of 24 well 
plates with sticky tabs. Cells were subsequently added to peptide-coated apatite films in 
serum-free media for 3 hours. Adherent cells were measured using a WST-1 assay and a 
standard curve from 100-10,000 cells. Cells were subsequently fixed, F-actin was stained 
with Rhodhamine-Pholloidin, and nuclei were stained with DAPI. Cell number was 
evaluated using Image J and compared to the WST-1 assay standard curve. Cell 
spreading was qualitatively evaluated.  
CELL SPREADING AND HISTOMORPHOMETRY 
Mineralized films were attached to the bottom of 24-well plates using sticky tabs. Films 
were subsequently incubated in 100 μg/mL of peptide solution for 3 hrs. Human bone 
marrow stromal cells were plated at 3000 cells/cm
2
 (n=6/group) with and without serum 
for 12 hrs. at 37
o
C and 5% CO2. Cells were fixed in 10% phosphate buffered formalin, 
permeabilized in Triton X and stained with Rhodhamine-pholloidin(Life technologies) 
for F-actin and anti-vinculin-Alexa 488 for focal adhesions. Nuclei were counterstained 
and cells were mounted in DAPI containing Vectashield(Vector Labs). Images were 
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acquired using a Nikon Ti Eclipse confocal microscope was used to image fluorescent 
sections. Cell counts and spreading were evaluated using Image J (NIH). A total of 4 
samples per group with 10 fields of view per sample at 20x were imaged to attain 
histomorphometric data. Cell diameter was measured using pholloidin and vinculin as 
cell boundary measures. Vinculin labeling was used to measure focal contact distribution. 
A modified concentric circle algorithm combined with particle measurements was used to 
evaluate total focal contacts from the outermost region from the cell center to the 
innermost region[29].  
MSC DIFFERENTIATION ON PEPTIDE COATED APATITE  
Mineralized films were held in place with Teflon O-rings for proliferation and 
differentiation assays to prevent films from floating. Films were subsequently incubated 
in 100 μg/mL of peptide solution for 3 hrs. iPS-MSCs were plated at 15,000 cells/cm2 
and grown to confluence until differentiated in complete media containing osteogenic 
factors (10
-8
M Dexamethasone, 2-5mM β-glycerophosphate, 10-4 M ascorbic acid). Cells 
were differentiated for 0, 3, 7, 10, 14, 21, 28 days and collected (n=3/group, 6 biological 
replicates pooled pairwise) in TRIZOL® (ThermoFisher Scientific). The manufacturer’s 
protocol for mRNA extraction was followed for isolation of mRNA. Briefly, cells were 
homogenized in TRIZOL®, phase-separated in chloroform, and RNA was precipitated in 
500uL isopropanol. RNA was subsequently washed in 80% ethanol, dried and dissolved 
in RNA grade double distilled water (Millipore) at 70
o
C. The amount of RNA was 
measured using a spectrophotometer and 1g was used for reverse transcription using 
SuperScript II reagents (ThermoFisher Scientific). TaqMan® Universal PCR Master Mix 
and TaqMan® primer probes were used for all qRT-PCR reactions. Cycle threshold (CT) 
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values were normalized to GAPDH expression and day zero values were used to attain 
ΔΔCT values. Gene expression was expressed as a fold change 2 
-ΔΔC
T. Cells cultured on 
TCPS were stained using the Von Kossa method and images were acquired using a Leica 
dissection microscope.  
PEPTIDE CELL INTERNALIZATION 
Cells were plated at 15,000 cells/cm
2
 on tissue culture treated glass coverslips in 24 well 
plates overnight in alpha-mem +10% FBS + 0.1% P/S at 37
o
C and 5% CO2. Peptides 
were dissolved in ddH2O and diluted to 300M in OPTIMEM (Invitrogen Carlsbad, 
CA). Media was removed from adherent cells, which were incubated in 300M of FITC-
VTK and OPTIMEM control media for 1hr. Cells were subsequently washed in PBS, 
fixed in 10% formalin, and mounted on glass slides in Vectashield containing the nuclear 
stain DAPI (Vector Labs Burlingame, CA). Nikon Ti-Eclipse confocal microscope was 
used to gather (n=10) images per group across 4 samples. Each fluorescent channel, 
DAPI and FITC, was imaged individually and images were merged using Image J.  
MSC RECRUITMENT ON PEPTIDE COATED APATITE 
To address the ability of DPI-VTK to specifically recruit multi-potent MSCs from 
primary bone marrow, murine bone marrow stromal cells were harvested from femora 
and tibiae of 5-6 week old C57/BL 6 mice (Jackson Laboratories). Cells were added to 
peptide coated apatite films and untreated controls in complete and serum-free media. 
Non-adherent cells were removed and complete media was replaced after 3 days of 
attachment. Adherent cells were collected after 5 days, counted using a hemocytometer, 
expanded, and proliferation (n=6/group) and differentiation (n=3/group, 6 biological 
replicates pooled pairwise) of adherent cell populations were examined on TCPS. Cell 
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proliferation was measured using CellTracker assay at 0, 3, 7, 10, and 14 days. Cell 
differentiation was assessed visually by observing mineral formation and staining using 
the Von Kossa method on day 14, 17, 21, and 28.   
STATISTICAL METHODS  
All statistical analysis was done using SigmaPlot 13.0 (Systat Software Inc). One-way 
ANOVA with Tukey tests for pairwise comparisons was used to assess initial cell 
recruitment across peptide groups. Two-way ANOVA with Tukey tests for pairwise 
comparison was used to assess cell spreading(peptide, serum condition), competitive 
inhibition (peptide, inhibitor), cell proliferation(peptide, time) and differentiation(peptide, 
time). Three-way ANOVA with Tukey test for pairwise comparisons was used to 
evaluate focal adhesion contact distribution (peptide, serum condition, section from cell 
center).  
RESULTS 
MSC SPREADING AND CONTACT DISTRIBUTION ON PEPTIDE COATED APATITE 
In serum-free media, cells interacting with DPI-VTK had a significantly greater cell 
diameter (Fig 3.1a,c) than cells on BLM (p < 0.001). In serum, cells attaching to DPI-
VTK had a significantly greater cell diameter than cells attached to RGD-VTK (p < 
0.02). However, cells interacting with RGD-VTK formed significantly more contacts 
than cells on either BLM or DPI-VTK in the serum free condition (Fig 3.1b,c; p < 0.001). 
Cells cultured with both RGD-VTK (p < 0.004) and DPI-VTK (p < 0.014) were able to 
form significantly more contacts than cells on BLM in serum. Cells on DPI-VTK formed 
significantly more contacts in serum compared to serum-free media (p < 0.002).  
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There were a significantly greater number of contacts at the periphery of the cells 
(sections 1-2) than at the center (sections 5,6) (p < 0.01), except on BLM in the serum-
free condition (Fig 3.1d). Cells cultured on DPI-VTK and RGD-VTK demonstrated a 
significantly greater number of cell contacts towards the periphery (sections 1-3) 
compared to BLM (p < 0.001) in both culture conditions.  
COMPETITIVE MSC BINDING ASSAYS  
Cell attachment was significantly greater in the absence of soluble RGD compared to all 
concentrations and across both peptide groups (p <0.001). Cell attachment was 
significantly greater in the presence of 0.01mM soluble RGD compared to 0.1 or 1mM 
RGD (Fig. 3.2a; p < 0.02). There was significantly greater cell spreading in the absence 
of soluble RGD on both DPI-VTK and RGD-VTK (Fig 3.2b). There were significantly 
less adherent cell fractions in the presence of RGD binding integrin subunits versus the 
collagen binding integrin (p < 0.001) on both DPI-VTK and RGD-VTK coated apatite 
films (Fig 3.2c). The adherent cell fraction on DPI-VTK in the presence of αV, α5, and β3 
was significantly greater compared to RGD-VTK, indicating a weaker interaction 
between these domains and DPI peptide compared to RGD.  
MSC PROLIFERATION ON PEPTIDE COATED APATITE  
Cells cultured on BLM with RGD-VTK had significantly higher cell numbers at 18 hr 
compared to cells cultured on BLM (Fig. 3.3; p < 0.016). However, by day 7, there was a 
significant increase in cell number between DPI-VTK and BLM (p < 0.001). Cell 
numbers on DPI-VTK were also significantly higher than on VTK and RGD-VTK on day 
10 (p < 0.05). By day 10 cells reached a saturation density beyond which proliferation 
slowed down and cell number exceeded detectable limits of the assay.  
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MSC DIFFERENTIATION ON PEPTIDE COATED APATITE 
iPS-MSCs were cultured on TCPS to verify osteogenic differentiation potential and 
relative gene expression levels were expressed as fold changes 2
- ΔΔCT
 (Fig 3.4). The 
osteogenic transcription factor Runx2 is elevated by day 10 followed by an increase in 
Osterix, indicative of early stage induction of osteogenic differentiation (Fig 3.4a,b). 
Markers of osteogenic differentiation alkaline phosphatase (ALP), osteocalcin (OCN),  
osteopontin (OPN), and bone sialoprotein (BSP) were all elevated by day 20 (Fig 3.4c-f), 
which coincided with mineralization  (Fig 3.4g). The osteogenic genes Runx2 at day 10, 
OSX at day 15, ALP starting at day 10, OCN starting at Day 10, OPN starting at day 28 
and BSP starting at day 20 were greater on TCPS compared to biomimetic apatite(Fig 
3.4a-c, Fig 5 a-c; p < 0.001). Therefore, mineralized films were used as a baseline for 
comparing iPS-MSC differentiation on peptide coated apatite films (Fig 3.5). Although 
fold changes are depicted, ΔΔCT values were used for all statistical analyses.  iPS-MSCs 
cultured on VTK (p < 0.001) and DPI-VTK (p < 0.023) had significantly greater Runx2 
expression(Fig 3.5a) compared to apatite films, whereas RGD exhibited no difference. 
All peptide groups had significantly increased Runx2 expression on day 7 compared to 
day 0, whereas Runx2 increased by day 10 on apatite controls (p < 0.05). RGD-VTK (p < 
0.001) and VTK (p < 0.01) had greater OSX expression(Fig 3.5b)  compared to apatite. 
Across all groups, OSX peaked at day 10 (p < 0.001). Similarly across all groups, ALP 
expression(Fig 3.5c) was greater on days 14, 21, and 28 compared to days 3 and 7 (p < 
0.001). Both DPI-VTK at day 14 and VTK starting at day 20 exhibited higher OCN(Fig 
3.5d) expression compared to BLM (p < 0.001). OPN(Fig 3.5e) and BSP(Fig 3.5f) 
expression on VTK coated apatite substrates was significantly higher than the other 
peptide and control groups (p < 0.001).  
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PEPTIDE INTERNALIZATION 
Fluorescently tagged peptides associate with cells and internalize within 1hr of 
incubation (Fig. 3.6). The fibrillar pattern of FITC fluorescence is indicative of 
cytoskeletal association. Moreover, punctate vesicular association indicates intracellular 
processing of the peptides.  
MULTIPOTENT-MSC RECRUITMENT FROM MURINE BONE MARROW  
Improving the recruitment of multi-potent MSCs from bone marrow can have a 
significant impact on cell-based therapies. After 5 days of attachment, a greater number 
of cells adhered to VTK coated BLM (Fig 3.7a) compared to TCPS (p < 0.017), BLM (p 
< 0.05), and DPI-VTK without serum (p < 0.001). More cells adhered to DPI-VTK than 
TCPS (p < 0 .05) and DPI-VTK (p < 0.008) without serum. There were more cells from 
the VTK-adherent population by day 10 (Fig 3.7b) compared to DPI-VTK adherent 
population in the no serum condition (p < 0.004).  
DISCUSSION 
DPI-VTK improves cell spreading and proliferation on apatite substrates compared to 
control and non-peptide coated surfaces, however differentiation and cell recruitment 
data suggest a biological effect is induced by VTK alone. Cells interact with material 
surfaces through adsorbed serum proteins such as fibronectin (Fn) and vitronectin (Vn). 
Interaction with serum components is also responsible for proliferation and 
differentiation of mesenchymal stem cells. Cell spreading and focal contacts on DPI-
VTK are greater in the presence of serum compared to no serum, indicating a cooperative 
interaction between serum components and DPI-VTK(Fig 3.1). Conversely, RGD-VTK 
did not increase cell spreading, indicating a non-cooperative interaction with serum 
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proteins. This is consistent with the attributed negative interaction between RGD peptides 
and serum proteins [19], [30].  
The greater percentage of cell contacts on DPI-VTK and RGD-VTK at the periphery of 
cells is indicative of greater adhesion strength(Fig 3.1 d,e). Focal adhesions result from 
an aggregation of integrin clustering and maturation of focal complexes[31], [32].  These 
transmembrane complexes are further reinforced by tethering the extracellular matrix to 
stabilizing actin-myosin cytoskeletal structures. As cells spread, focal adhesion 
reorganization and tension within the cytoskeleton can impart biological effects through 
phosphorylation of tyrosine kinases in signal transduction cascades regulating osteogenic 
differentiation[33], [34].  Decoupling the contributions of spatial distribution of adhesive 
complexes and cell spreading indicate the importance of focal adhesion distribution in 
regulating adhesion strength independent of the size and spread area of focal 
adhesions[35].  In addition to cell-peptide interactions, focal adhesion formation and 
distribution can also be regulated by underlying substrate stiffness [36]. Matrix elasticity, 
independent of soluble factors, is capable of driving differentiation. Surface roughness 
and surface chemistry of apatite films also play an important role on focal contact 
distribution in the presence of serum[12], [29].  The predominant effect of the underlying 
substrate properties is reflected in the similarities of spreading and contact distribution of 
cells in the presence of serum.  
The increase in adhesion strength (Chapter 2) of MSCs on DPI-VTK coated apatite 
compared to RGD-VTK and VTK spurned further investigation of the mechanisms 
mediating cell-peptide interaction. Competition with soluble RGD indicated the role of 
RGD binding integrins in mediating cell-DPI interactions(Fig 3.2a). Furthermore, 
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inhibition of cell spreading on DPI-VTK in the presence of soluble RGD demonstrated 
the requirement of RGD binding integrins in mediating cell spreading on DPI-VTK.  
Competition with RGD-binding integrin antibodies α5, β1, αV, β3, β5 further confirmed the 
role of DPI-VTK mediated cell attachment towards RGD-binding integrins(Fig 3.2c). 
However, the differences in adherent cell fractions between DPI-VTK and RGD-VTK in 
the presence of integrin antibodies can be attributed to either different affinities or 
conformational flexibility in binding different integrin domains. The reduced cell 
attachment on DPI-VTK in the presence of the collagen binding integrin α2β1  also reveals 
some binding to this receptor with weaker affinity than to the RGD binding integrin 
subunits. This weak association may arise from the conformational flexibility in binding 
the β1 subunit.  
The promiscuity of DPI-VTK adhesion to various RGD binding integrins can be 
attributed to phage display selection of cell surface targets that are highly expressed. 
MSCs express a distinct profile of integrins at distinct differentiation times [18], [37], 
[38]. The phage display derived cell binding sequence, DPI, could be selective towards a 
profile of integrins. Although an explicit DPI-VTK cell binding domain was not 
identified, the competitive inhibition findings suggest a role of RGD binding integrin 
mediated cell attachment towards DPI-VTK, while maintaining specificity towards 
MSCs.  
Initially adherent cell fractions were greater on RGD-VTK compared to DPI-VTK 
consistent with previous studies[22]. Although initial adherent cells are greater on RGD-
VTK, there were more adherent cells on DPI-VTK compared to apatite and VTK by day 
7(Fig 3.3). Greater proliferation on DPI-VTK compared to VTK can result from co-
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operative serum interactions coupled with integrin mediated attachment. MSCs reached a 
surface saturation density by day 10. Early expression of Runx2 and OSX followed by 
increased ALP expression indicate osteogenic differentiation of MSCs on DPI-VTK(Fig 
3.5). Interestingly MSCs cultured on VTK exhibit elevated gene expression for 
differentiation markers OCN, SPPI, and BSP compared to apatite films. The 
osteoinductive properties of VTK can arise from an indirect physiochemical interaction 
with the cell secreted mineral or through a direct cellular interaction. Addition of soluble 
VTK indicates cell association, internalization, and intracellular compartmentalization 
suggests a role in direct osteogenic induction(Fig 3.6).  
Interestingly, murine bone marrow stromal cell derived MSCs that were bound to VTK 
coated apatite substrates exhibited a much greater proliferation rate (Fig 3.7b). Moreover 
there were a greater number of adherent cells to VTK compared to DPI-VTK and DPI-
VTK without serum (Fig 3.7a). Increased proliferation of  VTK extracted cells indicates a 
more rapidly self-renewing population, often a characteristic of multipotent MSCs,  or the 
ability of VTK to promote proliferation of initially adherent fractions. Inability of VTK to 
promote multipotent hBMSC proliferation (Fig 3.3) indicates a greater likelihood of a 
rapidly self-renewing population initially adherent to VTK coated apatite.  However, 
none of the initially adherent cells across peptide and control groups differentiated in 
vitro to form mineralized cultures (data not shown). Future studies sorting fluorescent 
VTK and DPI labeled cells using conventional markers and testing multipotency can 
more thoroughly identify the specificity of DPI towards multi-potent MSC sub 
populations. Efficiently identifying multipotent-MSCs can reduce ex vivo expansion 
times, improve consistent expansion profiles, and reduce time and costs for cell-based 
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therapies.  Furthermore, selectively recruiting multipotent-MSCs  towards a biomaterial 
can improve tissue regeneration outcomes in vivo.  
Taken together, phage display derived DPI-VTK peptide is an integrin associated MSC 
specific sequence that improves cell adhesion strength and promotes cell proliferation. 
Although there was a marginal improvement of MSC differentiation on DPI-VTK 
compared to apatite films, MSC specificity towards DPI-VTK, cooperative interactions 
with serum proteins, improved proliferation and improved adhesion strength (Chapter 2) 
compared to untreated mineral and can translate to improved cell delivery and tissue 
regeneration outcomes in vivo.  
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CHAPTER THREE TABLES 
TABLE 3.1 PEPTIDE PROPERTIES  
Peptide Sequence Description 
MW 
(g/mol) 
Net 
Charge 
Acidic 
residues 
VTK VTKHLNQISQSY 
Phage derived mineral 
binding sequence 
 
1417.5
9 
 
1 2 
DPI-
VTK 
GGDPIYALSWSGMAGG
GSVTKHLNQISQSY 
Dual functioning 
peptide containing 
phage derived cell and 
mineral binding 
sequences 
 
3025.3
5 
 
0 5 
RGD-
VTK 
GGRGDGGGSVTKHLNQ
ISQSY 
Dual functioning peptide 
containing cell binding 
control sequence 
2061.2
0 
 
1 3 
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CHAPTER THREE FIGURES 
FIGURE 3.1(A-E) CELL SPREADING AND CONTACT DISTRIBUTION ON 
PEPTIDE COATED APATITE SURFACES 
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Figure 3.1. Cell spreading and contact distribution on peptide coated apatite surfaces. A) 
HBMSC diameter in serum and serum free conditions on peptide coated and uncoated 
mineralized substrates. Bars indicate significance within peptide groups. * indicates 
significantly different than BLM (p < 0.01). ** indicates significantly greater than RGD-
VTK (p < 0.02). B) Total number of HBMSC focal contacts in the presence and absence 
of serum on peptide coated apatite films and un coated controls. *, **, *** indicate 
significant difference from biomimetic apatite (p<0.001), (p<0.014), (p <0.004) 
respectively. Bars indicate significant difference between serum and non-serum 
conditions (p<0.001) C) HBMSCs labeled with DAPI and anti-vinculin tagged with 
Alexa 488 demonstrating a greater number of adhesion contacts in serum vs. no serum 
conditions. RGD-VTK formed the most contacts in serum free media. However these 
differences in focal contacts are mitigated by the addition of serum (scale bar 5 µm). D) 
Focal contact distribution in the absence of serum. Significant differences between 
sections 1 and 2, compared to 5 and 6 (p < 0.01) except on uncoated BLM. E) Focal 
contact distribution in the presence of serum. Significant differences between section 1 
and 2, compared to 5 and 6 (p < 0.01). 
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FIGURE 3.2(A-C). IPS-MSC COMPETITION WITH SOLUBLE INTEGRIN 
BINDING COMPETITORS. 
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Figure 3.2. iPS-MSC competition with soluble integrin binding competitors. A) 
Fraction of adherent cells on peptide coated apatite in the presence of soluble RGD 
normalized to no soluble competitors. * denotes significant difference from remaining 
concentrations within peptide group (p<0.01). ** denotes significant difference from the 
0.1 and 1mM concentrations (p<0.02) within each peptide group. B) Representative 
images at 40x of MSCs on DPI-VTK and RGD-VTK coated substrates in the presence 
and absence of soluble RGD. Nuclei are stained with DAPI and F-actin is stained with 
Rhodhamine-Pholloidin (scale bars 5 µm). C) Fraction of adherent cells on peptide 
coated apatite in the presence of RGD integrin binding antibodies and  Col1binding 
antibodies normalized to cell bound in the absence of soluble competitors. * denotes 
difference from RGD binding integrins (p <0.001). Bars denote difference from RGD-
VTK within same soluble treatment group (p <0.05). 
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FIGURE 3.3. MSC PROLIFERATION ON PEPTIDE COATED APATITE 
SUBSTRATES. 
 
Figure 3.3. MSC proliferation on peptide coated apatite substrates. Histomorphometric 
analysis of 4 samples per group covering 10 fields of view per sample was analyzed to 
quantify the number of cells. * different from TCPS and apatite controls  (p < 0.001). * 
Different from apatite control (p < 0.001). **  Different from VTK (p < 0.05). 
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FIGURE 3.4(A-G). IPS-MSC DIFFERENTIATION ON TCPS IN OSTEOGENIC 
MEDIA. 
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Figure 3.4. iPS-MSC differentiation on TCPS in osteogenic media. A,B). Relative gene 
expression of osteogenic transcription factors Runx2 and Osterix normalized to day zero 
and GAPDH values (n=3). C-F) relative gene expression of genes regulating osteogenic 
markers ALP, OCN, OPN, and BSP normalized to day zero and GAPDH values (n=3). 
G)  von Kossa staining of mineral. 
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FIGURE 3.5(A-F). DIFFERENTIATION OF IPS-MSCS ON BIOMIMETIC 
APATITE AND PEPTIDE COATED APATITE 
 
Figure 3.5. Differentiation of iPS-MSCs on biomimetic apatite and peptide coated apatite. 
A,B). Relative gene expression of osteogenic transcription factors Runx2 and OSX 
normalized to day zero and GAPDH values (n=3/group, 6 biological replicates pooled 
pairwise). C-F) relative gene expression of genes regulating osteogenic markers ALP, 
OCN, OPN, and BSP normalized to day zero and GAPDH values (n=3/group, 6 biological 
replicates pooled pairwise) 
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FIGURE 3.6. CELL ASSOCIATION OF FLUORESCENTLY TAGGED VTK 
PEPTIDE AFTER 1 HR OF INCUBATION. 
 
Figure 3.6. Cell association of fluorescently tagged VTK peptide after 1 hr of 
incubation. The pattern of internalization is indicative of cytoskeletal association. 
Association in punctate vesicular structures indicates intracellular processing. 
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FIGURE 3.7. MULTIPOTENT MURINE-MSC RECRUITMENT ONTO 
PEPTIDE COATED APATITE 
 
         
Multipotent MSC recruitment on peptide coated apatite. A) Initial adherent cell numbers 
on peptide coated apatite and controls. * significant from DPI-VTK no serum (p<0.001). 
B) Proliferation of adherent cell fractions plates at 3000cells/cm
2
 on TCPS for 10 days. * 
significant from DPI-VTK no serum (p<0.001). 
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CHAPTER FOUR 
IMPROVING MSC BASED BONE TISSUE REGENERATION IN 
VIVO USING CELL-SPECIFIC PEPTIDE COATED MINERALIZED 
BIOMATERIALS 
 
INTRODUCTION 
There are over 2 million bone grafting procedures worldwide with 500, 000 bone grafting 
procedures/year in the US alone required for the treatment of critical sized defects e[1], 
[2]. Autograft therapies utilizing resected host bone are the gold standard for bone 
augmentation and bone grafting, but are limited in availability and often result in donor 
site morbidity[3]. Allogenic bone or demineralized bone matrix from cadaveric sources 
are often used as an alternative, but exhibit a reduction in cellularity and vascularization 
with increased reabsorption rates [4]. Synthetic bone grafts using calcium phosphates, 
calcium sulfates, collagen, and collagen mineral composites promote osteoconduction at 
the defect site, but exhibit limited osteoinductivity[5]. As a result these materials are co-
delivered with adsorbed growth factors which can result in further complications. The 
limitations of current therapies, coupled with an increasing aging population and 
increasing global access to healthcare, drive the need for new regenerative strategies that 
can alleviate the economic burden of non-union defects[6].
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Cell based therapies are a promising alternative for conventional auto and allograft 
therapies[7]–[9]. Bioresorbable natural and synthetic polymers, calcium phosphates and 
sulfates and polymer mineral composites materials are often considered for delivering 
cell based therapies[10], [11].    Amongst these materials, biodegradable synthetic 
polymers of the α-hydroxyester family, specifically the co-polymer poly(D,L-lactide-co-
glycolide), are also considered for their improved control over mechanical properties, 
chemical functionalization, degradation rates, and ease of manufacture compared to 
naturally derived polymers[12]–[14]. The mineral component provides mechanical 
support and recapitulates the chemical microenvironment conducive for 
osteogenecity[15], [16].  Amongst the various methods of incorporating a mineral 
component onto a soft material, growth of a heterogeneous mineral layer by immersion in 
simulated body fluid (SBF) containing the ionic concentrations of blood plasma under 
physiological pH is a promising strategy. [16]–[18].  
A continuous mineral coating throughout a porous polymer scaffold can protect the 
polymer from hydrophilic attack consequently attenuating polymer degradation rates[15], 
[19].  The concentration of SBF can also control the physical and chemical properties of 
the mineral coating and which subsequently affects mineral dissolution rates. For 
instance,  mineral precipitated from 2x SBF concentrations are more amorphous than 1x 
SBF and results in faster dissolution rates. Therefore characteristics of precipitated 
mineral coating can also be used to further control polymer degradation timeframes[17].  
Coating polymer substrates with bone-like-mineral (BLM) improves osteoconductivity in 
vitro and in vivo[14], [15], [20]. Although dissolution byproducts of the mineral coating 
have been implicated in biological activity, the chemical and physical properties of the 
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mineral alone are insufficient to promote osteoinductivity. Nanoscale morphology, 
crystallinity, and compositional characteristics of the mineral surface drive the adsorption 
of serum proteins which subsequently affect osteoconduction[21]–[23]. However, the 
adhesion of cells to mineral-adsorbed serum proteins is non-specific and indiscriminative 
of bone forming cell populations. To improve bone forming cell specific attachment  and 
osteoinductivity of mineral substrates, tissue engineers utilize extracellular matrix 
proteins, peptides, and motifs specific to integrin binding domains. For instance, integrins 
α2β1 and α5β1 promote osteoinductivy by mechanotransductively activating osteogenic 
differentiation pathways. Derivatives of extracellular protein cell binding motifs that bind 
α2β1 and α5β1, such as RGD and Col(a1) derived peptides like GFOGER and N-
GTPGPQGIAGQRGVV-C (P15), are used to further enhance osteoconductivity and 
osteoinductivity [24]–[26].   
Due to the limitations of immobilizing peptide to mineral substrates, ECM proteins 
associated with binding mineral are used for appropriate delivery and presentation of cell 
adhesive peptides[27], [28]. For instance the glutamic acid repeat motif(E7) in bone 
sialoprotien was combined with RGD to improve adsorption and promote 
osteoconductivity and osteoinductivity of mineral substrates[29]. Although RGD-E7 
peptide improves osteoconductivity and osteoinductivity on mineral substrates in vitro, it 
surprisingly inhibits osseointegration in vivo[26]. The varied successes with RGD and 
various integrin binding peptides prompted the identification of cell specific peptides that 
can selectively bind bone forming cell populations form a heterogeneous stem or 
progenitor source. A mineral binding peptide is also required to improve adsorption to the 
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apatite surface and control presentation of the cell specific peptide to the cell surface 
receptor.  
To meet these objectives, we used a commercially available phage display coupled with 
bioinformatic approaches and in vitro screening techniques to identify MSC specific 
[DPIYALSWSGMA, DPI] and apatite specific [VTKHLNQISQSY, VTK] sequences 
which were combined into a dual peptide 
[GGDPIYALSWSGMAGGGSVTKHLNQISQSY, DPI-VTK] for cell specific 
recruitment to mineral substrates. DPI-VTK efficiently targets apatite substrates and 
improves adhesion strength and specificity to murine bone marrow, human bone marrow, 
and induced pluripotent stem cell(iPS) derived mesenchymal stem cells(MSCs)[30]. 
Moreover, DPI-VTK improves spreading and proliferation while supporting 
differentiation on dual peptide coated constructs compared to uncoated controls (Chapter 
3). These findings suggest a role for in vivo biological potential  
In addition to improving the quantity of tissue through improved conductivity and 
inductivity, improving the uniformity of newly reconstructed tissue throughout the defect 
site is an important regeneration outcomes. In this study we hypothesize that uniformity 
of mineral coverage, uniformity of DPI-VTK adsorption and consequent uniformity of 
ips-MSC distribution in vitro contribute to increase quantity and uniform distribution of 
bone regenerated in vivo compared to non-peptide coated controls. The ubiquitous cell 
binding domain RGD was combined with the mineral binding domain VTK to be used as 
a dual-peptide positive control (RGD-VTK) for in vitro characterization (Table 4.1). P15 
peptide, a component of Pep-Gen P15-BGS (Dentsply Implants, CA) currently available 
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as a bone graft substitute for void filling and augmentation in the oral cavity[31], was 
used as an in vivo control.  
MATERIALS AND METHODS 
SCAFFOLD FABRICATION  
Polylactic-co-glycolic acid(PLGA  85:15 , Lakeshore Biomaterials) was solubilized in 
chloroform at 5%w/v. NaCl was sieved to 250-425µm and packed into 5mm diameter 
well in a Delrin® mold. PLGA-chloroform solution was added to each well of the Delrin 
mold which was subsequently covered and dried for 36hrs. The mold was transferred to a 
vacuum chamber for 5 days and subsequently leached in double-distilled water (ddH2O) 
for 36hrs with intermittent fluid changes. Leached scaffolds were etched in 0.5M sodium 
hydroxide under slight agitation and rinsed twice in ddH2O.  
SCAFFOLD MINERALIZATION 
Scaffolds were mineralized by filtration of simulated body fluid(SBF) through the 
interconnected pores as previously described[19]. SBF (1x)  contains 141 mM NaCl, 4.0 
mM KCl, 0.5 mM MgSO4, 1.0 mM MgCl2, 4.2 mM NaHCO3, 5.0 mM CaCl2•2H2O,and 
2.0 mM KH2PO4[32]. SBF was sterile filtered using a 0.22µm filter and 0.005% sodium 
azide was added to prevent bacterial contamination. 2x SBF and 4x SBF solutions titrated 
to pH 6.4 with 1M NaOH were used with the filtration method.  A Delrin® mold 
containing leached and etched scaffolds was attached to the actuator of an Instron 8521 
servo-hydraulic system. The mold was lowered into a base containing sufficient pre-
warmed 4x SBF (37
o
C) to fully submerge all scaffolds during the course of 
mineralization. The fully submerged mold was cycled in the base at an amplitude of 
25.4mm at 0.011Hz.  The 4x SBF was changed every 6 hours the first day and was 
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replaced with 2x SBF which was changed every 12 hours on days 2-5. Solution 
temperature in the base was maintained at 37
o
C using a heating sleeve connected to a 
thermocouple and temperature controller (Extech Instruments, Model 48VTR). 
Mineralized scaffolds (5mm diameter x 2 mm thickness) were carefully detached from 
the mold, rinsed in ddH2O for 12 hrs, air-dried in a biosafety cabinet for 12 hrs and stored 
in a desiccator. Scaffolds were distributed evenly across control and treatment groups to 
improve mean MV% and variance (Fig. 4.1i).  
SCAFFOLD CHARACTERIZATION 
Morphology of mineralized PLGA scaffolds was assessed using scanning electron 
microscopy (Philips XL30 FEG SEM). Scaffolds were gold coated and assessed at 20kV 
(n=9 total). Scanco  μCT 100 was used to examine mineralization of scaffolds at 10 μm 
voxel size at 10 μm slice increments. MicroCT scans were attained at 70kV, 114 A using 
a 0.5 Al filter. Reconstructed images of all mineralized scaffolds were analyzed using the 
Scanco μCT_evaluation tool to calculate mineral volume fractions (MV%). 
Reconstructed images were rendered in (MicroView, Parallax Innovations Inc) using the 
isosurface tool at a threshold of 1000 with the smoothing filter and a surface quality 
factor of 0.51 (n=10/group). A custom volumetric shrinkage application was used to 
generate five concentric volumetric shells each 20% smaller than the previous volume. 
Mineral volume fractions were calculated for each shell and compared across the five 
volumetric shells to examine mineral distribution from the exterior toward the interior of 
the scaffold.  
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PEPTIDE SYNTHESIS AND CHARACTERIZATION 
Peptides (Table 4.1) were synthesized at the University of Michigan peptide core. All 
peptides were chemically synthesized using solid phase synthesis and protective 
chemistry. HPLC was used to verify > 95% purity. Peptides were stored at -20
o
C until 
use.  
PEPTIDE LOADING AND CHARACTERIZATION 
Scaffolds pre-wet overnight in ddH2O were sterilized, transferred to a new micro-plate, 
and incubated in Trizma buffer for 4hrs at 37
o
C. Peptides were weighed, dissolved in 
sterile ddH2O, and diluted in Trizma buffer pH 7.4. Trizma pre-incubated scaffolds were 
immersed in peptide solution (100ug/mL) and set on a shaker under gentle agitation for 
3hrs at 37
o
C. Pierce BCA assay (Thermo-Fisher Scientific Inc.) was used to determine 
total peptide amount on scaffolds (n=6/group) and compared to a standard curve (1-
200µg/mL).  Peptide distribution on scaffolds was assessed using fluorescein 
isothiocyanote (FITC) tagged peptides  (n=6/group). FITC-VTK has equivalent binding 
affinity to apatite as unlabeled peptide. Fluorescently tagged peptide coated scaffolds 
were paper-embedded in cryosection molds in freezing media (OCT, Tissue Tek) on a 
bed of dry ice and acetone[33]. A Leica cryostat was used to make five 200µm thick 
sections along the thickness of each scaffold. Sections were mounted in Vectashield 
(Vector Laboratories) and imaged using a Nikon Ti-Eclipse confocal microscope. 
Sections were imaged at constant intensity and gain settings across all samples using a 4x 
objective that incorporated the entire section in the field of view[34]. Edges were clipped 
to limit artifact and 40 images were acquired along the thickness of each section at 5µm 
intervals. Image J software (NIH) was used to stack 40 images projected in the Z 
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direction based on average intensity. A modified concentric circle algorithm was used to 
measure fluorescence intensity or cell counts within each concentric circle (outmost 
circle(a) for section 1 to innermost circle(e) for section 5) (Fig. 4.1b,c-g). Intensity 
measurements were correlated with corresponding sections to assess distribution from the 
outside to the interior of the scaffold.  
CELL CULTURE 
Mesenchymal stem cells derived from induced pluripotent stem cells (iPS-MSCs) were a 
generous gift from Dr. Paul Krebsbach. These cells were verified for osteogenic 
differentiation and bone forming potential in vivo[35]. iPS-MSCs were cultured in (α-
MEM), 10% FBS, antibiotics, 200mM L-glutamine, and 10mM non-essential amino 
acids. iPS-MSCs (passage 5) were expanded twice (passage 7) when they reached 80-
90% confluence before transplantation. Growth media was replaced every 2-3 days and 
switched to osteogenic media supplemented with osteogenic factors (10
-8
M 
Dexamethasone, 2-5mM β-glycerophosphate, 10-4 M ascorbic acid) for 7 days prior to 
transplantation.  
CELL SEEDING ON PEPTIDE COATED SCAFFOLDS 
Peptide-coated scaffolds were placed into 100uL PCR tubes. Confluent IPS-MSCs 
(passage 7) were trypsinized and suspended in either serum-free or complete media in a 
20µL volume containing 50,000 cells. Cell suspension was added to each scaffold within 
each PCR tube for 3hrs at 5% CO2 and 37
o
C. Cells seeded on peptide-laden scaffolds 
(n=6/group) were fixed in 10% phosphate buffered formalin.  Fixed cell-seeded scaffolds 
were paper embedded in cryosection molds in freezing media (OCT, Tissue Tek) on a 
bed of dry ice and acetone[33]. A Leica cryostat was used to make five 200µm thick 
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sections along the thickness of each scaffold. Cell-seeded scaffold sections were dried, 
permeablized in Triton X, and stained with DAPI. All sections were mounted in 
Vectashield (Vector Laboratories) and imaged using a Nikon Ti-Eclipse confocal 
microscope. Sections were imaged at constant intensity and gain settings across all 
samples using a 4x objective that incorporated the entire section in the field of view[34]. 
Edges were clipped to limit artifact and 40 images were acquired along the thickness of 
each section at 5µm intervals. Image J software (NIH) was used to stack 40 images 
projected in the Z direction based on average intensity. A modified concentric circle 
algorithm used for peptide distribution analysis was used to measure cell counts from the 
outside to the interior of the scaffold.  
SUBCUTANEOUS TRANSPLANTATION OF CELL-SEEDED CONSTRUCTS 
Peptide coated scaffolds and uncoated mineralized control scaffolds were placed in PCR 
tubes and statically seeded in a 20µL volume of complete media at 3 x 10
6
 cells/construct 
for 3 hours. This micromass seeding method was used to improve seeding efficiency on 
peptide coated constructs. Moreover, a significantly higher cell number than in vitro 
studies was used to ensure bone formation in an ectopic model[36].  The cell seeded 
mineralized scaffolds and mineralized-peptide-laden scaffolds (n=10/group) were then 
stored on ice prior to transplantation and cell counts in the remaining volume of media in 
tube were used to calculate seeding efficiency.  Acellular mineralized scaffolds and 
acellular mineralized scaffolds coated with DPI-VTK were included as controls 
(n=4/group). NIH guidelines for the care and use of laboratory animals (NIH Publication 
#85-23 Rev. 1985) were adhered to. All surgical procedures were performed in 
accordance with University of Michigan’s Committee on Use and Care of Animals. Male 
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nude mice (NIH-Lyst
bg-J
Foxn1
nu
Btk
xid
, Charles Rivers) between 25-30g were 
anesthetized with isoflurane in O2 (5% induction and 2% maintenance at 1mL/min).  A 
midline longitudinal incision was made on the back of each mouse and 4 pockets (2 on 
each side) were made in the subcutaneous tissue beneath the dorsal skin.  Cell seeded 
constructs were placed into each pocket and the incision was closed with surgical staples. 
Animals were sacrificed 8 weeks postoperatively and transplants were harvested.  
OSSICLE MICROCOMPUTED TOMOGRAPHY 
Ossicles of regenerated bone were fixed in 4% phosphate buffered formalin, embedded in 
agarose and imaged in a Scanco μCT 100 at 12 μm voxel size at 12 μm slice increments 
at 70kV, 114 A using a 0.5 Al filter. Reconstructed images were rendered in MicroView ( 
Parallax Innovations Inc) using the iso-surface tool with the smoothing filter and a 
surface quality factor of 0.51 (n=10/group). Advanced ROI tool, combined with 
histogram values were used to calculate bone volume fraction (BVF). A custom 
volumetric shrinkage application in MATLAB was used to generate five concentric 
volumetric shells each 20% smaller than the previous volume. Bone volume fractions 
were calculated for each shell and compared across the five volumetric shells to examine 
mineral distribution from the exterior toward the interior of the scaffold. 
OSSICLE HISTOLOGY AND HISTOMORPHOMETRY 
Osscicles were retrieved from agarose and decalcified in 10% EDTA. Transplants 
(n=5/group) were sectioned through the midline, paraffin embedded, and 5µm thick 
triplicate sections were made of 3 ossicle regions progressing from the interior to the 
periphery. Sections were subsequently deparaffinized, hydrated, and stained with 
hematoxylin and eosin. Sections were scored using parameters outlined in Table 4.2[37], 
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[38]. A 20x field of view was used to scan sections and assess bone coverage.  Totals for 
each ossicle region were averaged.  
STATISTICAL METHODS 
Statistical analysis was conducted using Sigmaplot 13.0. One-way ANOVA on ranks 
using Tukey test for pairwise comparison was used to compare peptide adsorption, cell 
seeding efficiency, and bone quality across treatment groups. One-Way ANOVA on 
ranks with Dunn test for pairwise comparisons was used to assess bone volume fractions. 
Two-Way ANOVA on ranks using Tukey test for pairwise comparisons was used to 
assess peptide, cell, mineral and bone volume distribution.  Multiple and single linear 
regression were conducted across peptide groups, cell distribution, peptide distribution, 
mineral distribution, bone volume distribution and histological bone scores.  
RESULTS 
CHARACTERIZATION OF MINERALIZED SCAFFOLDS 
Continuous mineral coverage on porous PLGA scaffolds was visually verified across all 
batches using SEM (Fig 4.1 a,b). Average mineral volume fractions (MV%) for all 
treatment groups were 16.5±3.8% (Fig 4.1i).  Filtration of SBF resulted in mineralization 
throughout each scaffold (Fig 4.1, d-i). There was a greater fraction of mineral in the 
interior region compared to shells 1 and 2 (p < 0.001, n=10/group). Greater 
mineralization in the interior region may arise from increased turbulent flow conditions, 
and early nucleation within the interior of the scaffold pores. Regardless, there was no 
observable pore occlusion which limits transport and vascularization.  
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PEPTIDE LOADING ON MINERALIZED SCAFFOLDS 
Peptide adsorption on mineralized scaffolds was consistent no significantly different 
between VTK, DPI-VTK and RGD-VTK groups (Fig 4.2a, n=6/group). The amount of 
P15 adsorbed to the scaffold surface (0.75 ±0.053 nmols, n=6/group) was less than DPI-
VTK (p <0.001) , RGD-VTK (p <0.01)  and VTK (p <0.001).  Adsorbed VTK, DPI-VTK 
and RGD-VTK were distributed uniformly across scaffold sections spanning from the 
periphery to the innermost shell (Fig 4.2 c-h).  Fraction of adsorbed peptide was not 
significantly different within peptide groups (Fig 4.2h). There was a higher adsorbed 
fraction of VTK than RGD-VTK in the outermost section (p <0.02).  
CELL ATTACHMENT AND DISTRIBUTION ON PEPTIDE-LADEN SCAFFOLDS 
Cells adhered readily to DPI-VTK coated mineral scaffolds (Fig. 4.3 a). Seeding 50,000 
cells on a DPI-VTK coated scaffold (Fig. 4.3a) did not result in the surface saturation 
with cells evident on scaffolds seeded with 3 x 10
6
 cells for in-vivo implantation (Fig. 
4.3b-d).  There was more efficient IPS-MSC seeding on VTK (p<0.04), DPI-VTK 
(p<0.002), RGD-VTK (p<0.001), and serum coated BLM (p<0.001) compared to serum- 
free BLM control groups (Fig 4.3e). RGD-VTK exhibited higher seeding efficiency than 
BLM (p <0.001), VTK (p<0.001), and DPI-VTK (p<0.01). Seeding efficiency was 
greater on DPI-VTK and serum-coated BLM compared to VTK (p < 0.05). The fraction 
of cells adherent to VTK in the outermost section of the mineralized scaffold was greater 
than BLM with serum (Fig. 4.3f; p <0.02). Moreover, the fraction of cells adherent to the 
outermost section on VTK coated scaffolds was greater than the middle and inner-most 
sections (Fig. 4.3g; p<0.001). Seeding efficiency on scaffolds prior to in vivo 
implantation was 98.3% ±5.35% across all peptide and control groups (n=6/group).   
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OSSICLE BONE VOLUME FRACTION AND DISTRIBUTION 
MicroCT images reveal, qualitatively greater bone formation on scaffolds with DPI-VTK 
(Fig 4e) and P15 (Fig 4.4f) compared to scaffolds with cells, but no peptide (Fig, 4.4c), 
scaffolds with just the mineral-binding peptide (Fig. 4.4d) and acellular controls (Fig 
4.4a,b) controls. However, scaffolds coated with both DPI-VTK and P15 exhibited shell 
formation characteristic of ectopically reconstructed ossicles. MicroCT analysis (Fig 
4.4g) quantify the greater BVF in constructs coated with DPI-VTK compared to VTK (p 
< 0.002), BLM (p <0.037), acellular DPI-VTK (p <0.003) and acellular BLM controls (p 
<0.00). P15 coated constructs had greater BVF than BLM(p <0.05) and acellular BLM (p 
<0.005). There were noticeable differences between VTK coated constructs and uncoated 
and acellular controls, however the large and unequal variance resulted in failed 
significance.  Total volumes were also greater for DPI-VTK and P15 groups compared to 
BLM, VTK and acellular controls (Fig 4.4h, p <0.001).  
Rendered MicroCT images of concentric shells of regenerated bone (Fig 4.5b-f) revealed 
greater bone formation towards the peripheral sections compared to interior sections. 
There were no significant differences in bone volume within sections across peptide 
groups (Fig 4.5g). VTK coated constructs had a significantly greater fraction of bone in 
section 2 compared to sections 4 (p<0.004) and 5 (p <0.026). DPI-VTK coated constructs 
had a greater fraction of bone in section 1 compared to section 5 (p<0.002) and section 4 
(p<0.003), as well as a greater fraction of bone in section 2 compared to section 5 
(p<0.005) and section 4 (p<0.008).  Similarly, P15 coated constructs had a greater 
fraction of bone in section 1 compared to section 5 (p<0.004) and section 4 (p<0.005), as 
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well as a greater fraction of bone in section 2 compared to section 5 (p<0.015) and 
section 4 (p<0.019).  
HISTOLOGY OF RECONSTRUCTED OSSICLES 
There was greater bone formation on DPI-VTK and P15 coated constructs compared to 
VTK and BLM constructs (Fig 4.6 a-h). Ossicles from BLM and VTK demonstrated 
some bone formation surrounding  scaffold pores (p), however the DPI-VTK and P15 
constructs were relatively devoid of pores(p) and struts(t).  Ossicles from BLM and VTK 
coated scaffolds look compressed and elongated compared to pre-transplanted scaffolds, 
whereas DPI-VTK and P15 constructs appear larger than the originally transplanted 
constructs which is consistent with total volumes. Regenerated bone from DPI-VTK and 
P15 also demonstrated greater vascularization (h) and cellularity (c) compared to VTK 
coated and BLM constructs. Bone score indicate greater bone formation on DPI-VTK 
and P-15 compared to VTK and BLM (Fig. 4.6i; p <0.001).  There were no significant 
differences in bone score within different sections of scaffolds for each peptide group 
(Fig 6j).  Across sections (Fig 6k), DPI-VTK and P15 exhibited greater bone scores 
compared to VTK and BLM (p <0.001).   
REGRESSION ANALYSIS 
Multivariate linear regression revealed no correlation between in vitro cell distribution, 
peptide distribution, and mineral distribution on bone distribution in vivo. Similarly 
regressing bone distribution against in vitro cell distribution, peptide distribution, and 
mineral distribution by individual treatment group revealed no correlation with a desired 
p<0.05. Regressing cell distribution against mineral distribution and peptide distribution 
 94 
revealed no correlation with P <0.05. Similarly regressing cell distribution by individual 
treatment group revealed no correlation with a desired p<0.05.  
DISCUSSION 
DPI-VTK coated on mineralized PLGA constructs improved overall bone formation in a 
ectopic model compared to non-peptide coated, VTK and acellular controls. Moreover, 
bone formed by DPI-VTK coated constructs exhibited increased cellularity and 
vascularization compared to uncoated, VTK and acellular controls. However, uniform 
peptide distribution, cell distribution, and mineral distribution did not correlate to 
improved bone distribution in vivo.  
Peptides containing the VTK, DPI-VTK, and RGD-VTK mineral specific sequence 
improved overall adsorption to mineral and delivery of cell binding sequences to apatite 
compared to collagen derived P15 sequence (Fig 4.2a). The increase in mineral binding 
between VTK vs. RGD-VTK in the outermost region of mineralized scaffolds can result 
from different packing efficiencies arising from conformational differences in solution 
and bound states. Furthermore VTK and RGD-VTK both have a net charge of 1 however; 
the distribution of charged residues within the peptide can result in varying steric 
repulsions when saturating the mineral surface.  
Although less RGD-VTK was bound in the outermost region of the construct(Fig 4.2h), 
there were no observable differences in the fraction of bound cells between VTK and 
RGD-VTK in the outermost region(Fig 4.3f). Cell attachment to DPI-VTK is improved 
compared to BLM without serum and VTK without serum.  Although cell seeding 
efficiency on DPI-VTK is equivalent to RGD-VTK and BLM in serum, the DPI peptide 
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promotes cell specific attachment to MSC whereas RGD and serum proteins are non-
specific. Moreover,  RGD coated substrates exhibit poorer osteogenic activity in vivo 
hypothesized to result from unfavorable serum protein interactions[26], [39].  However, 
DPI-VTK cooperatively interacts with serum proteins towards improving MSC 
attachment (Chapter 2). The cell-specific interaction combined with cooperative serum 
interaction could also play a role in observed improvements in the quantity and quality of 
bone formation in vivo. Serum-free or xeno-free media are increasingly used to meet 
current good manufacturing practices for clinical grade MSCs in order to limit risk of 
disease transmission and immunogenicity while maintaining consistency of appropriately 
tested and qualified starting materials[40]–[42]. The ability of DPI-VTK to attach 
equivalent numbers of cells in serum free media as serum coated BLM also implies a 
potential ex vivo application for serum-free expansion on mineral substrates[43], [44].  
Cell-seeded mineralized scaffolds containing DPI-VTK significantly improved the total 
volume, the volume fraction and bone scores compared to VTK coated and uncoated 
BLM, and acellular BLM and DPI-VTK scaffolds (Fig 4.4). Acellular mineral and 
acellular DPI-VTK was unable to form bone in the ectopic mouse model. Although the 
adipose tissue surrounding the ectopic implantation pocket contain a resident population 
of mesenchymal stem cells, the low percentage of mesenchymal cells within the tissue 
and their location with respect to the DPI-VTK transplant may preclude infiltration and 
recruitment. Furthermore, the rate of degradation of the mineral and construct can impact 
conduction. Regardless, both acellular BLM and acellular DPI-VTK coated constructs 
provide a baseline for comparing transplanted IPS-MSC driven tissue reconstruction on 
control and peptide coated substrates.  
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Initial mineral volumes are commonly subtracted from the final bone volumes in order to 
calculate total regenerated bone volume.  However, these calculations assume inert 
mineral substrates that do not dissolve over the course of the transplantation. The 
mineralized PLGA substrate coated with 2x SBF results in a rapidly dissolving mineral 
substrate that is nearly resorbed as evidenced in the acellular controls.  Even within 
cellularized constructs, the 2x precipitated SBF results in poor bone formation compared 
to previous studies utilizing 1x SBF precipitated mineral[45]. Moreover, a thrombin-
fibrin clot is typically used to provide further retention of cells within the construct. The 
inability to use the fibrin clot in order to directly test peptide-cell effects resulted in poor 
bone formation on BLM constructs compared to previously observed studies.   Although 
there were no significant differences in total volume, bone volume fraction or bone scores 
of regenerated bone between P15 and DPI-VTK coated cellular constructs, further 
engineering the dual-peptide sequence to improve cell specificity can drive greater bone 
formation.  
Cell-seeded constructs, especially those containing MSCs, can drive vascularization 
through secretion of pro-angiogenic factors contributing to hematopoiesis which 
concomitantly drives greater bone formation[46], [47]. Hematopoietic regions were 
evident across all cell-transplanted treatment groups. Greater cell numbers were observed 
within constructs coated with DPI-VTK and P-15(Fig 4.6). VTK cell-seeded constructs 
exhibited observably greater bone formation compared to BLM controls and acellular 
controls however the variance was too large for significance.  
Bone regenerated from murine bone marrow stromal cells on a mineralized PLGA 
scaffold construct in an ectopic mouse model exhibited  90% of cells with donor origin 
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up to 12 weeks post transplantation[45], [48], [49]. MSC driven bone formation on β-
TCP constructs also reveals retention of donor cells for up to 45 weeks post 
transplantation[50]. It can be inferred that the majority of cells present within DPI-VTK 
and P15 are from a donor origin. Moreover, the limited cellularity within acellular DPI-
VTK and acellular BLM constructs further indicates the lack of host cell contribution to 
regenerating ectopic ossicles.  Taken together, the ability of DPI-VTK to sequester donor 
cells and/or recruit host cells within transplanted constructs is one of the leading drivers 
of improved quantity and quality of bone formation.   
However, regression analysis indicates no correlation between in vitro mineralization, 
peptide distribution, cell distribution and in vivo bone formation. Furthermore, a 
characteristic shell of bone indicating non-uniformity was evident in both P15 and DPI-
VTK coated constructs (Fig 4.5). A shell is commonly formed in an ectopic model[48], 
[51], [52]. The subcutaneous environment is physically and temporally limited by the 
ability to form deeply penetrating vascular networks before cell mediated mineral 
formation causes pore occlusion and  isolation of the interior regions[53].Furthermore, 
attenuated clearance of biomaterial substrate degradation byproducts can increase toxicity 
of the interior microenvironment adding to the shell [54]. Another artifact arising from 
the shell formation could cause attenuated degradation of the scaffold interior resulting in 
higher measured bone volume fractions. There was limited to no evidence of this artifact 
from histological assessment of bone (Fig 4.6). Bony spicules within the center regions of 
both DPI-VTK coated and P15 coated constructs exhibited thick cellularized sections 
which are inconsistent with latent mineral from pre-implanted sources. Despite the shell 
 98 
formation, DPI-VTK promoted moderate bone formation penetrating 60% of the scaffold 
interior.  
Osteoinductive potential of DPI-VTK could also be a contributing factor towards 
improved bone formation. DPI-VTK competes with many of the same integrin domains 
involved in osteogenic differentiation namely α5β1 and β5 domain(Chapter 2). These 
domains are implicated in osteoblastic differentiation and could drive the differentiation 
of initially adherent cell fractions. P15 is also suggested to promote osteogenic 
differentiation through the α2β1 cell binding domain which is implicated in activation of 
osteoblastic differentiation pathways [25]. 
The marked improvement in in vivo osteogenic potential of DPI-VTK compared to non-
peptide coated constructs warrants further investigation towards the mechanism of action. 
Future studies to elucidate specific cell binding targets in addition to conformational 
regulation DPI sequence when present with the VTK sequence can further improve the 
osteogenic potential of these phage derived peptides. As tissue engineering shifts from 
developing technologies to meet general clinical challenges to addressing more focused 
clinical applications, there will be an increased need for delivering cell specific cues to 
material surfaces with defined surface chemistries [7], [55]. Combinatorial phage display 
is a powerful technology platform to enable focused cell based tissue regeneration 
through the discovery of cell specific and material specific peptide sequences. 
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CHAPTER FOUR TABLES 
TABLE 4.1 PEPTIDE PROPERTIES  
Peptide Sequence Description 
MW 
(g/mol) 
Net 
Charge 
Acidic 
residues 
VTK VTKHLNQISQSY 
Phage derived mineral 
binding sequence 
 
 
1417.59 
 
1 2 
DPI-
VTK 
GGDPIYALSWSGMAGG
GSVTKHLNQISQSY 
Dual functioning 
peptide containing 
phage derived cell and 
mineral binding 
sequences 
 
3025.35 
 
0 5 
RGD-
VTK 
GGRGDGGGSVTKHLN
QISQSY 
Dual functioning 
peptide containing cell 
binding control 
sequence and phage 
derived mineral binding 
sequence 
2061.20 
 
1 3 
P15 
GTPGPQGIAGQRGVV 
[23] 
Col1a1 derived cell and 
mineral binding peptide 
for in vivo control  
1393.57 
 
1 0 
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TABLE 4.2 HISTOLOGY SCORING PARAMETERS 
 
Score Bone Coverage 
0 No Bone  
1 1%-5% in a particular region 
2 5%-10% in a particular region 
3 10%-25% throughout section 
4 >25% throughout section 
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CHAPTER FOUR FIGURES  
FIGURE 4.1(A-J) MORPHOLOGY AND DISTRIBUTION OF BONE-LIKE 
MINERAL PRECIPITATED ON PLGA SCAFFOLDS 
 
A B 
C D E 
F G H 
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Figure 4.1: Morphology and distribution of bone-like mineral precipitated on PLGA 
scaffolds. Representative SEM images of mineralized scaffolds at A)low and B)high 
magnification. scale bars 200µm and 50µm respectively. C)Representative MicroCT 
image of mineralized scaffold rendered in MicroView® D-H)Representative images of 
mineral distribution volumetric shells progressing from the outermost to innermost 
regions of the scaffold. I) Mineral volume fraction across peptide groups.  Fraction of 
mineral volume progressing from the outermost to the innermost volumetric shell of the 
scaffold (J).  * indicates significant difference from section 1 and 2 (p<0.001).  
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FIGURE 4.2(A-H). PEPTIDE ADSORPTION AND DISTRIBUTION ON 
MINERALIZED PLGA SCAFFOLDS. 
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Figure 4.2. Peptide adsorption and distribution on mineralized PLGA Scaffolds. (A) 
Peptide adsorption evaluated by BCA assay demonstrates no significant differences 
across peptide groups. (B) Schematic depicting relative position of each cryosection 
within the scaffold. (C-F) Representative images of DPI-VTK distribution on PLGA 
mineralized scaffolds with (a-e) regions indicating sampled area within corresponding 
sections. Each image is a composite stack of 40 images projected in the Z direction based 
on average intensity (scale bar 0.5mm). (H) Uniform distribution of adsorbed peptide 
(n=6) across all groups was analyzed using Image J(NIH) software with a customized 
concentric circle algorithm. * indicates significantly different from Section 1 of RGD-
VTK (p <0.02).   
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FIGURE 4.3(A-G) - CELL SEEDING EFFICIENCY AND CELL DISTRIBUTION 
ON PEPTIDE COATED SCAFFOLDS. 
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Figure 4.3 - Cell Seeding efficiency and distribution on peptide coated scaffolds. A) 
DAPI stained cells on DPI-VTK coated scaffolds at 50,000 cells/scaffold (scale bar 500 
µm). B) DAPI stained cells on scaffolds to be used for in vivo implantation at 3x106 
cells/scaffold (scale bar 200µm). C) Top and D) bottom view of scaffolds before 
implantation indicating complete surface saturation and clustering around scaffold pores 
indicated by arrows(scale bar 100µm). E) Seeding efficiency on peptide coated scaffolds 
based on histomorphometric analysis. *** indicates significant difference from DPI-VTK 
(p<0.01), VTK (p<0.001), and BLM (p<0.001). ** indicates significant difference from 
VTK (p <0.05) and BLM (p <0.002) groups. * indicates significant difference from BLM 
(p<0.04) group. F) Fraction of adherent cells as a function of spatial location indicating 
higher cell fraction bound to VTK in section 1 compared to BLM (*, p<0.02). G) 
Fraction of adherent cells by peptide groups indicating higher cell fractions bound to 
section 1 compared to sections 3, 4, and 5 (*, p<0.001). 
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FIGURE 4.4(A-H). BONE VOLUME FRACTIONS OF ECTOPICALLY 
REGENERATED OSSICLES 8 WEEKS POST TRANSPLANTATION. 
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Figure 4.4. Bone volume fractions of ectopically regenerated ossicles 8 weeks post 
transplantation. Representative rendered MicroView® images of A) acellular BLM, B) 
acellular BLM containing DPI-VTK, C) BLM with iPS-MSCs, D) BLM containing VTK 
with iPS-MSCs, E) BLM containing DPI- VTK with iPS-MSCs, F) P15 coated BLM 
constructs (scale bar=1mm). G) Bone volume fractions from MicroCT analysis indicate 
greater bone formation in scaffolds with DPI-VTK and P15 compared to VTK, BLM, 
DPI-VTK acellular and BLM acellular controls. * indicates a significant difference from 
BLM and acellular BLM (p <0.003). ** indicates a significant difference from VTK (p < 
0.017),BLM (p <0.001), acellular DPI-VTK (p <0.002) and acellular BLM controls (p 
<0.01).  H) Total volume is greater on DPI-VTK and P15 compared to  
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FIGURE 4.5(A-H). BONE DISTRIBUTION IN ECTOPICALLY REGENERATED 
OSSICLES 8 WEEKS POST TRANSPLANTATION. 
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Figure 4.5. Bone distribution in ectopically regenerated ossicles 8 weeks post 
transplantation. A) Representative rendered MicroCT image of ossicle regenerated from 
cell seeded DPI-VTK coated mineralized scaffold (1mm scale bar). B-F) Concentric 
volumetric shells progressing from the outermost to innermost region of regenerated 
ossicle. G) Fraction of total bone by section indicating no significant differences in % of 
total bone in each section amongst peptides. H) Fraction of total bone by peptide 
revealing greater fraction of bone towards the periphery compared to the interior regions 
in peptide groups. * indicates significant difference from sections 4 and 5. 
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FIGURE 4.6(A-K). HISTOLOGICAL STAINING AND BONE QUALITY 
SCORING OF ECTOPICALLY REGENERATED OSSICLES 8 WEEKS POST 
TRANSPLANTATION. 
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Figure 4.6. Histological staining and bone quality scoring of ectopically regenerated 
ossicles 8 weeks post transplantation. A-D) Representative low magnification images of 
cross sections through the center of ossicles indicating overall degree of bone formation 
in the interior of the construct (scale bar 500µm). E-H) High Magnification images of 
cross sections through the center of ossicles indicating increased bone formation, 
vascularization, and cellularity on DPI-VTK and P15 compared to VTK and BLM. (b) 
indicates bone, (h) indicates hematopoesis, (c) indicates greater density of cells, (p) 
indicates pores, (t) indicate scaffold struts replaced by tissue (scale bars 100µm). I) Bone 
score based on bone coverage. * indicates significant differences from BLM and VTK (p 
<0.001).  J) Bone Score by peptide group across innermost section 1 to outermost section 
3. K) Bone score by section across peptide groups. * indicates significant difference from 
BLM and VTK (p<0.001).  
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CHAPTER FIVE 
SUMMARY AND FUTURE WORK 
 
The work in this dissertation addressed the discovery and design of novel peptides for 
tissue engineering. Bony non-unions arising from pathological conditions or trauma are 
often surrounded by poorly cellularized tissue with interrupted vasculature, further 
attenuating regenerative bridging processes. Cell-based therapies to heal critical sized 
defects through de novo tissue regeneration are a promising alternative to conventional 
auto-,  allo- and xenograft therapies. The primary objectives for tissue engineering 
require the mechanical, structural and compositional properties of regenerated tissue to 
seamlessly match those of native tissues surrounding non-unions and critical sized 
defects[1].  
Biomaterial carriers used to deliver cells to a defect site provide physical support, as well 
as instructive cues. A multitude of stem and progenitor cell sources from various lineages 
and anatomic locations show promise in regenerating defects for a multitude of clinical 
applications[2]–[5]. For instance, mesenchymal stem cells from both adult and neonatal 
sources, as well as pluripotent stem cells from both embryonic and induced systems, are 
commonly considered for tissue regeneration applications[6]–[8]. Similarly, a variety of 
biomaterial carriers are used to deliver cells to defects. For instance, natural and synthetic 
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polymers, polymer-mineral composites, and  biomineral composites are used to heal 
critical sized bone defects. Biomaterial design strategies that control the attachment and 
delivery of specific regenerative cell populations to a critical size defect can promote 
functional tissue regeneration  in vivo[9], [10]. Moreover, strategies to specifically recruit 
host cells towards biomaterial implants can further improve the quantity and quality of 
regenerated tissue. In addition to tissue regeneration strategies, grafting to bridge non-
unions can also be improved though specific host cell recruitment to implanted metal, 
ceramic and polymer biomaterials.   
Use of display technologies to identify cell specific targets is prevalent in the areas of 
oncology and immunology. Many of the monoclonal antibody based therapeutics are 
generated from humanizing antibodies from animal sources using phage display. Through 
a combinatorial phage display, we identified bone marrow MSC binding 
(DPIYALSWSGMA-DPI) and mineral binding sequences (VTKHLNQISQSY-VTK), 
and combined them with glycine linkers to form a dual-functioning cell and mineral 
binding peptide (GGDPIYALSWSGMAGGGSVTKHLNQISQSY, DPI-VTK)[11], [12]. 
The work presented in this thesis demonstrated that DPI-VTK improves adhesion 
strength towards MSCs compared to fibroblasts and pre-osteoblasts (Chapter 2), 
promotes spreading and proliferation on mineral substrates compared to apatite controls 
through an RGD integrin binding receptor, and supports differentiation of adherent MSCs 
(Chapter 3). Delivering MSCs on a mineralized porous polymer scaffold coated with 
DPI-VTK improves the quantity and quality of bone compared to uncoated and acellular 
controls (Chapter 4).  
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PHAGE DISPLAY DERIVED PEPTIDE DESIGN  
The DPI sequence, when added to VTK, directly or indirectly regulates attachment to 
apatite (Chapter 2, Table 2). DPI-VTKphos, containing phosphorylated serine residues in 
the VTK domain, resulted in less adsorption to apatite, a result which is contrary to the 
greater binding affinity of VTKphos compared to VTK.  Apatite binding affinity 
differences between DPI-VTK and DPI-VTKphos can be driven by differences in solution 
state conformation, as well as degree of freedom in bound state peptide conformation. 
For instance, the binding DPI to the apatite surface using the VTK peptide can improve 
the conformational flexibility of DPI compared to delivery with DPI-VTKphos. The bound 
state conformation of DPI-VTKphos also limited hBMSC adhesion strength towards 
apatite surfaces. Cell attachment to VTK indicates potential cell association with the 
mineral binding sequence however the lack of spreading and adhesion strength on these 
surfaces indicates that the DPI sequence exhibits greater cell binding affinity.  
The greater specificity of MSCs toward DPI-VTK indicates affinity towards a cell 
specific target. Phage display on clonally derived human bone marrow stromal cells 
identified peptide sequences that bound specifically to cell surface receptors. MSC 
surfaces contain a variety of receptors involved in signal transduction, ion transport, and 
cell adhesion. There is an equal likelihood of phage display identifying peptide sequences 
that bind specifically to the most highly expressed cell surface receptor or the most highly 
expressed profile of cell surface receptors. The relative promiscuity of DPI-VTK towards 
the RGD binding integrin receptor subunits suggests either a non-integrin mediated cell 
attachment, specificity to a profile of integrins expressed on MSCs, or a combination of 
these mechanisms.  
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Integrins can direct osteoinduction by transducing mechanical stimuli from the 
extracellular matrix into biological responses. For instance, α2β1 and α5β1 are involved in 
osteogenic differentiation of MSCs and osteoblasts through the MAPK/PI3K/ERK 
pathways [13]–[16]. DPI-VTK demonstrates competition with both α5 and β1 antibody in 
solution and partial competition with α2β1 in solution. Furthermore, the ability to 
specifically adhere MSCs may arise from the conformational flexibility of DPI when 
binding various integrin receptors.  Designing peptide sequences that target a profile of 
integrin receptors can be a promising design strategy to deliver greater numbers of 
specific regenerative cell populations on a biomaterial to a critical sized defect.  
DUAL-PEPTIDE TISSUE ENGINEERING APPLICATIONS 
DPI-VTK improved cell proliferation on apatite coated substrates compared to 
biomimetic apatite without peptide and with just the mineral binding peptide VTK  
(Chapter 3 Figure 3). The role of integrin mediated attachment to DPI-VTK can explain 
the greater proliferation of cells on DPI-VTK. DPI-VTK also supports osteogenic 
differentiation in vitro. ALP and OCN expression was increased in MSCs cultured on 
DPI-VTK compared to apatite surfaces with serum or the dual peptide RGD-VTK. 
Surprisingly, there was an increase in osteogenic markers on VTK compared to DPI-
VTK, apatite controls and RGD-VTK. The inductive role of VTK may be affiliated with 
the ability to associate with the cell surface and internalize. Further investigations 
regarding the translocation of VTK can elucidate osteoinductive mechanisms of action.  
Furthermore, understanding the stability, degradation rate, and potential translocation of 
cleaved VTK fragments from DPI-VTK coated apatite in the presence of cells, can 
provide further insight towards inductive mechanisms of DPI-VTK.  
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The in vivo biological activity of MSCs transplanted on DPI-VTK coated mineral-PLGA 
composite scaffolds was examined in an ectopic model (Chapter 4). Constructs 
containing DPI-VTK formed more bone, contained more cells, and exhibited greater 
vascularization compared to acellular controls, non-peptide coated apatite and VTK 
coated apatite. Increased bone formation with DPI-VTK can be attributed to improved 
cell attachment and potentially improved osteoinduction.   
However, uniformity of bone-like mineral coverage, peptide distribution and cell 
distribution did not result in uniform bone formation. The dynamics of bone formation 
within the subcutaneous environment may ultimately drive this characteristic shell 
formation. The subcutaneous environment is limited by the ability to form deeply 
penetrating vascular networks before cell mediated mineral formation causes peripheral 
pore occlusion causing isolation of the interior [17]. Evaluating bone regeneration in a 
critical-sized calvarial defect model may reveal the relative contributions of uniform 
mineral, peptide and cell distribution to in vivo bone formation.  
FUTURE DIRECTIONS 
Computational modeling identified basic Lys-3 and the polar residues Gln-10 and Tyr-12 
in the VTK sequence as key residues responsible for binding to apatite [18]. 
Computational modeling of DPI, DPI-VTK, and scrambled sequences coupled with solid-
state NMR or Raman spectroscopy could reveal sequence and conformational aspects 
that regulate cell and apatite specificity. This information regarding specific peptide 
sequence characteristics associated with cell binding and conformation will further 
improve peptide design and functionality[19], [20].  In addition to the cell and mineral 
binding domains, the linker sequence can be used to improve mineral binding and 
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mineral association. Identifying sequences and lengths of linkers that control solution and 
bound state conformation towards improving apatite affinity and cell attachment.  
In addition to promoting MSC specific attachment to apatite, DPI-VTK improves 
spreading in the presence of serum proteins, indicating a cooperative interaction (Chapter 
3). Peripheral focal contact distribution relates to adhesion strength and spreading area 
until a particular threshold of spread area[21]. The peripheral focal adhesion contact 
distribution on DPI-VTK clustered towards the peripheral sections compared to BLM in a 
no serum condition (Chapter 3. Figure 1c. p <0.001), which implies greater adhesion 
strength. A more rigorous detachment force assay using DPI-micropatterned surfaces and 
higher fluid shear forces could quantify the aggregate strength of focal contacts formed 
on DPI in relation to spread area during later stages of adhesion.  
Rigorous quantification of adhesion strength using the DPI sequence immobilized to a 
polymer substrate could be used to more specifically identify cell binding targets. 
Competitive inhibition assays can be coupled with adhesion strength assays to quantify 
binding affinity of DPI to a specific integrin or integrin subunit [22]–[24]. Fragmentation 
of the DPI sequence and sequence scrambling can also be used to identify amino acid 
residues in DPI that interact with cell surface receptors.  Finally, examining the role of 
DPI-MSC receptor mediated osteoinductivity through cytoskeletal, signal transduction, 
and mineralization inhibitors could provide further information regarding mechanism of 
action with relation to peptide design.  
Longitudinal in vivo studies using fluorescent peptide labeling, MSC-labeling, and in vivo 
imaging techniques can reveal the interplay between transplanted versus host cell 
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contributions towards increasing bone volume, cellularity, and vascularization. Although 
an ectopic model demonstrates proof-of-concept for in vivo biological activity, an 
orthotopic model provides a more clinically relevant environment to assess tissue 
regeneration. A critical sized calvarial defect model can be used  to assess the ability of 
DPI-VTK not only improve the ostoinductivity of transplanted cells but also recruit host 
cell populations, promote anastomosis and form penetrating vascular networks, and 
generate functional bone matching the structural and tissue level properties native bone.   
In addition to improving cell based therapies, DPI-VTK can also be applied towards 
functionalizing grafting materials. A variety of natural and synthetic materials are used 
for grafting, including synthetic hydroxyapatite, mineral substituted calcium phosphates 
and sulfates, collagen, mineral collagen composites, and synthetic biodegradable 
polymers. Although these materials are commonly used for bridging non critical-sized 
defects, they exhibit limited osteoinductivity, thereby requiring cells, growth factors or 
osteoinductive peptides to improve reconstruction of non-union defects. For instance, the 
osteoinductive peptide P15 adsorbed to bone graft substitutes is approved for clinical use 
in the oral cavity. Furthermore, the application of BMP2 antibodies, BMP2 mimicking 
peptides, and BMP2 sequestering receptors on bone grafting materials have shown 
promise in laboratory and clinical settings [25]–[27]. Verifying the osteoinductive 
potential of DPI-VTK in promoting host cell infiltration and osteoinduction in a critical-
sized calvarial defect model can provide further insight towards a clinical opportunity for 
bone grafting applications.  
The cell specific DPI sequence could be applied to separate or extract specific cell 
populations from primary tissues prior to ex vivo expansion. For instance, p-selectin 
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coated tubing was used to extract CD34+  at 94% purity and CD45+ at 93% purity 
compared to 74% purity with flow cytometer and ficoll extraction systems [28], [29]. 
Furthermore, sorting cells based on fluorescent-antibodies can interfere with cell 
proliferation and differentiation, while the adhesive nature of mononuclear cells results in 
loss during density gradient purification[30], [31]. Similarly, DPI-coated or immobilized 
substrates coupled with detachment flow technologies could be used to improve 
extraction purity of MSCs from primary tissue populations. Moreover, fluorescently 
labeled DPI peptide could be used to sort specific MSC subpopulations. Specifically 
extracting MSCs could significantly reduce ex vivo expansion time and subsequent time 
to therapy. Therefore, extracting cells using adhesion strength or fluorescent cell sorting 
can improve purity in a non-invasive manner. For instance, adhering populations of 
fibroblasts undergoing induced pluripotent reprogramming within a microfluidic 
substrate and subjecting them to fluidic flow to detach non-adherent cells can improve 
the extraction efficiency of specific iPSCs with up to 95% efficiency significantly 
reducing culture and characterization times.  
ADVANCEMENTS IN DISPLAY TECHNOLOGY 
At the time of discovery, there were relatively few studies utilizing phage display in 
tissue regeneration. However, over recent years phage display has been used to identify 
sequences specific towards various biomaterials and cells[32]–[38]. Furthermore, display 
technologies are becoming increasingly sophisticated by customizing the presentation 
and structure of the displayed proteins or peptides through organism selection, 
engineering coat proteins, or engineering fusion protein expression. For instance, 
retroviral, bacterial, yeast, mammalian and even ribosomal display systems are being 
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used to customize display technologies towards specific target identification[39]. 
Furthermore, the conformation of presented sequences are being engineered to provide 
more physiologically relevant secondary structures. For instance cyclized and bicyclized 
peptide libraries have been created to improve the specificity and binding affinity of 
identified sequences towards receptor targets[40], [41]. Advancements in computational 
processing power coupled with development of computational modeling algorithms for 
identifying structure function relationships have further expanded the potential for new 
molecule discovery[20], [42]. Coupling these advancements in display technologies with 
new methodologies for identifying specific binding targets can further improve display 
technology based biomolecular discovery towards tissue engineering applications.  
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APPENDICIES  
 
APPENDIX A ADSORPTION ISOTHERM 
 
Materials   
  Cat# Lot 
Hydroxyapatite 289396 MKBK2210V 
  
1. Trizma preset crystals T7818 pH 7.5 Batch 115k5423 
2. 96-well plate - corning clear bottom - UV grade plate 
3. 96-well plate black flat bottom  
4. Millipore filter plate  
5. FITC-BSA   
6. BSA  
  
Methods  
  
Trizma buffer preparation  
  
a. Make 50mM Trizma preset crystal pH 7.4 (MW = 151.6)  
i. 7.58g/L, 3.79g/500mL, 1.85g/250mL, 0.9475g/125mL 
  
HA Suspension preparation  
 (slurry is 25% w/v),    
  
b. Add 1 gram of HA/CaP + 24mL  buffer  --> pH 7.172 after 20hr incubation at 37
o
C  
c. Place on shaker plate to equilibrate overnight (~18 hrs)  
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d. Check pH   
 Verify consistent HA suspension  
a. Pipette 40mg/mL @ 50uL(3x), 100uL (3x), 200uL (3x) to verify consistency of 
pipetting equal amounts 
b. Pipette 20mg/mL @ 50uL(3x), 100uL (3x), 200uL (3x)…0mg/mL (see table) Add 
buffer for remaining volume so all wells have 200uL sln in them 
c. Incubate for 1hr on titer plate @ setting  5  and RT 
d. Choose lowest concentration of powder that is statistically significant from the 
concentration that is immediately greater 
e. Verify absorbance at 200, 250, 300, 350, 400, 450, 500nm 
Make peptide stock solution 
a. 1mg/ml stock --> 3mg in 3mL buffer 
b. Aliquot 1mL into eppendorf tubes 
Peptide Binding Assay 
1. Add 100 uL of dilution to 96 well plate in triplicate 0, 0.5, 1, 2.5, 5, 10, 25, 50, 75, 
100, 250, 500 μg/mL 
2. Repeat for standard curve 
3. Take pre-reading 200 -300 nm after incubation at 37oC for 15 min 
4. Transfer dilutions to 96 well Millipore filter plate 
5. Add 50uL of 10mg/mL HA suspension to samples 
6. Add 50uL of Trizma buffer to standard curve 
7. Incubate on shaker at 37oC for 4hrs 
8. Centrifuge plate @ 1000RPM for 20min  
9. Incubate at 37oC for 15 min 
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10. Take post reading 
Micro BCA Assay  
1. Preparation of working reagents 
2. Pipette 150uL into each well containing filtered solution 
3. Place on plate shaker for 30seconds 
4. Cover plate using sealing tape and incubate at 37oC for 2 hrs 
5. Cool plate to RT 
6. Measure absorbance at 562nm 
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APPENDIX B CELL CENTRIFUGATION ASSAY 
PLGA film fabrication 
Materials 
 85:15 poly-(D,L)-lactide-co-(glycolide) ester capped    (Lakeshore biomaterials, 
8515DLG7E) 
 Glass coverslips ( cat#64-703 Warner Instruments) 
 Chloroform (Sigma Aldrich, cat# 366919, batch 47796DM) 
 Sigmacote (Sigma Aldrich, SL2, Lot: 039K4364) 
 Plastic 100mm petri dishes (Corning) 
 Glass petri dishes  
 Glass vials 
 Kimwipes 
 PLGA films on glass coverslips 
 Plastic Petri dishes 
 1x mSBF  
 NaOH (Sigma-Aldrich, S2567, Lot: 127K6105) 
Methods 
Glassware prep 
1. Clean glass petri dish with chloroform removing all residual adherent polymer 
2. Wash with dH20 and soap  
3. Rinse in chloroform and let it evaporate 
4. Wash all glassware in sigmacote and evaporate overnight 
*sigma cote allows for easier removal of polymer from glass surface 
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Polymer solution prep 
1. Thaw out appropriate number of polymer pellet aliquots and bring to RT 
2. Weight out appropriate amount to make 5 wt% solution of PLGA: Chloroform 
3. Add PLGA to glass vial and add appropriate amount of chloroform to vial 
i. 1.186 g in 16mL = 5 wt% makes about 50-60 films 
ii. 0.5932 g in 8mLs =  5 wt% makes about 25-30 films 
4. Place on titer (setting 3) for 3-4hrs or overnight wrapped in aluminum foil 
Film preparation 
1. Place 6-7 glass coverslips in each glass petri dish 
2. Rinse glass syringe 2X with chloroform 
3. Load PLGA:Chloroform solution into syringe 
4. Gently and Smoothly inject 250-300uL of PLGA chloroform solution on to surface 
of each glass coverslip  
5. Dry overnight in fume hood 
6. Move glass petri dishes back to fume hood for 2-3 days 
7. Move films from glass petri dishes to plastic petri dishes lined with Kimwipes 
8. Cover with aluminum foil 
9. Store in desiccator for 2-3 days or for later use 
Notes 
 Sigmacote limits polymer adhesion to glass surface so glass prep does not need to be done 
for most of the dishes for up to 2weeks. It is recommended when batch processing films.  
  
 Inject polymer solution onto each film in one swift, smooth and gentle motion. Dripping 
can perturb surface tension and cause spillover 
  
 Do not bump into or knock against fume hood during or after film preparation to avoid 
spill over 
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 No other work should be done in fume hood until they have been moved to back of the fume 
hood the following day 
 
Mineralization of films 
Methods 
1. Add 50mL 0.5M NaOH to each 100mm
2
 plastic petri dish 
2. Remove films from desiccator  
3. Submerge films per dish in NaOH for 7 min 
4. Wash twice in 50mL ddH2O for 10 min each  
5. Add 50mL 1x mSBF in cell culture hood to new petri dishes 
6. Warm up the SBF to 37oC 
7. Add films to SBF cover dish and seal with parafilm 
8. Place at 37oC and replace SBF every day for 5-7 days 
9. Remove and rinse in ddH20 1x for 10 min 
10. Remove 1-3 samples to verify degree of mineralization and Ca/P ratio using SEM-EDX 
Preparation of biomaterial surfaces 
Make dBSA solution > block the background to improve signal: noise 
**specific time and temperature conditions of denaturation are very critical for proper 
blocking 
 Solubilize BSA 1.5 g in 150 mL PBS(1%) in a glass Nalgene bottle on stir plate using 
magnetic stir bar for 1hr 
 Pre-heat hybridization oven to 90oC 
 Microwave 300mL tap water in 500mL beaker until it reaches 90oC 
 Place 1% BSA solution bottle in hot water beaker and transfer to hybridization chamber.  
 Measure solution temperature of sample using thermocouple.  
 Start timer once solution temperature reaches 80
o
C.  
 Remove after 11-12 min. 
 Cool in RT water bath and sterile filter in cell culture hood.  
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Centrifugation Assay  
1. Wash cells in PBS 
2. Trypsinize Cells, stop in complete media and spin down 
3. Resuspend in serum free media and count 
4. Remove dBSA and add 50k cells/well 
5. Incubate at 37oC for 3 hrs 
6. Add 3.5mL PBS and seal 24 well plate with adhesive sealing film (Nalgene).  
7. Ensure no air-bubbles are present within wells.  
8. Centrifuge upside down at designated centrifugation speed.  
9. Wash and add 450uL serum free media to each well 
10. Add 50uL of WST1 reagent to each well 
11. Add water to the Von Kossa wells 
12. Transfer WST-1 reagent in duplicate to 96 well plate 
13. Take a reading of WST-1 @420nm on microplate reader after 4 hrs 
14. Take Post reading of von Kossa wells after 1 hr 
Histology 
1. Aliquot 5mL of Formalin 
2. Make 0.2% Triton X-100 (Sigma Aldrich, T8787 50mL) by diluting 10 μL of Triton X in 
4990uL of PBS 
a. Vortex thoroughly 
3. Wash cells twice with pre-warmed phosphate-buffered saline, pH 7.4 (PBS) 
4. Fix the sample in 10% formalin for 10 minutes at room temperature (1mL of fixative in 24 
well)  
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a. Tissue to fixative volume ratio should be 15-20% if specimen receives more, than 
recommended then it is ok, but undersaturation should be avoided.  
b. Note: Methanol can disrupt actin during the fixation process. Therefore, it is best to 
avoid any methanol containing fixatives. The preferred fixative is methanol-free 
formaldehyde. 
5. Wash two or more times with PBS. 
6. Place each coverslip in a glass petri dish and extract it with a solution of acetone at ≤–20°C 
or 0.1% Triton X-100 in PBS for 3 to 5 minutes. 
7. Wash two or more times with PBS. 
8. When staining with any of the fluorescent phallotoxins, dilute 5 μL methanolic stock 
solutioninto 200 μL PBS for each coverslipto be stained.  
a. To reduce nonspecific background staining with these conjugates, add 1% bovine 
serum albumin (BSA) to the staining solution. It may also be useful to pre-incubate 
fixed cells with PBS containing 1% BSA or with the Image-iT™FX signal enhancer 
(I36933) for 20–30 minutes prior to adding the phallotoxin staining solution. 
9. When staining more than one coverslip, adjust volumes accordingly. For a stronger signal, 
use 2 or 3 units per coverslip. 
10. Place the staining solution on the coverslip for 20 minutes at room temperature (generally, 
any temperature between 4°C and 37°C is suitable). To avoid evaporation, keep the 
coverslips inside a covered container during the incubation.  
11. Wash two or more times with PBS.  
12. For long-term storage, the cells should be air dried and then mounted in a permanent 
mountant such as ProLong® Gold reagent or Cytoseal. Specimens prepared in this manner 
retain actin staining for at least six months when stored in the dark at 2–6°C.  
 
